| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.387 | 0.069 | 0.387 | Immunosuppressant | 0.23 0.166 DBMET00946 | ||
| 0.303 | 0.029 | 0.303 | Calpain inhibitor | 0.227 0.088 DBMET00617 0.3 0.03 DBMET00946 | ||
| 0.365 | 0.103 | 0.66 | 5 Hydroxytryptamine release inhibitor | 0.495 0.034 DBMET00617 0.66 0.005 DBMET00946 | DBMET00946 | |
| 0.31 | 0.052 | 0.31 | Cardiotonic | 0.279 0.066 DBMET00946 | ||
| 0.291 | 0.049 | 0.535 | 5 Hydroxytryptamine uptake stimulant | 0.435 0.009 DBMET00617 0.535 0.004 DBMET00946 | DBMET00946 | |
| 0.276 | 0.039 | 0.276 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.26 0.053 DBMET00946 | ||
| 0.241 | 0.013 | 0.241 | Catenin beta inhibitor | 0.215 0.023 DBMET00946 | ||
| 0.36 | 0.14 | 0.535 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.535 0.02 DBMET00617 0.522 0.025 DBMET00946 | DBMET00617 | |
| 0.214 | 0.022 | 0.214 | Alkylator | 0.131 0.058 DBMET00617 0.123 0.065 DBMET00946 | ||
| 0.314 | 0.122 | 0.314 | 15-Lipoxygenase inhibitor | 0.289 0.138 DBMET00617 | ||
| 0.203 | 0.017 | 0.225 | Falcipain 3 inhibitor | 0.148 0.038 DBMET00617 0.225 0.012 DBMET00946 | DBMET00946 | |
| 0.197 | 0.01 | 0.242 | Folate antagonist | 0.242 0.005 DBMET00946 | DBMET00946 | |
| 0.248 | 0.07 | 0.399 | Tyrosine 3 hydroxylase inhibitor | 0.399 0.008 DBMET00617 0.347 0.017 DBMET00946 | DBMET00617 | |
| 0.246 | 0.084 | 0.388 | Gastrin inhibitor | 0.275 0.053 DBMET00617 0.388 0.005 DBMET00946 | DBMET00946 | |
| 0.251 | 0.095 | 0.384 | Insulysin inhibitor | 0.294 0.062 DBMET00617 0.384 0.025 DBMET00946 | DBMET00946 | |
| 0.183 | 0.04 | 0.819 | Alpha-N-acetylglucosaminidase inhibitor | 0.635 0.004 DBMET00617 0.819 0.002 DBMET00946 | DBMET00946 | |
| 0.247 | 0.106 | 0.247 | Ca(v)3.3 blocker | |||
| 0.27 | 0.135 | 0.406 | Calpain 2 inhibitor | 0.268 0.137 DBMET00617 0.406 0.058 DBMET00946 | DBMET00946 | |
| 0.206 | 0.079 | 0.295 | Nitric-oxide synthase stimulant | 0.295 0.013 DBMET00617 0.27 0.021 DBMET00946 | DBMET00617 | |
| 0.177 | 0.05 | 0.263 | Thiol protease inhibitor | 0.147 0.072 DBMET00617 0.263 0.024 DBMET00946 | DBMET00946 | |
| 0.224 | 0.099 | 0.446 | Interleukin agonist | 0.287 0.055 DBMET00617 0.446 0.013 DBMET00946 | DBMET00946 | |
| 0.134 | 0.01 | 0.134 | Histone deacetylase inhibitor | |||
| 0.136 | 0.018 | 0.166 | Somatostatin 1 agonist | 0.166 0.01 DBMET00946 | DBMET00946 | |
| 0.156 | 0.042 | 0.225 | Cathepsin H inhibitor | 0.225 0.017 DBMET00617 0.225 0.017 DBMET00946 | DBMET00946 | |
| 0.214 | 0.103 | 0.526 | Superoxide dismutase inhibitor | 0.375 0.031 DBMET00617 0.526 0.011 DBMET00946 | DBMET00946 | |
| 0.245 | 0.14 | 0.403 | Vasodilator, coronary | 0.276 0.108 DBMET00617 0.403 0.034 DBMET00946 | DBMET00946 | |
| 0.104 | 0.004 | 0.104 | Diamine oxidase inhibitor | 0.086 0.005 DBMET00617 | ||
| 0.141 | 0.043 | 0.141 | Papain-like protease (SARS coronavirus) inhibitor | 0.127 0.066 DBMET00946 | ||
| 0.287 | 0.195 | 0.287 | MAP kinase 1 inhibitor | |||
| 0.171 | 0.082 | 0.171 | MAP kinase kinase 5 inhibitor | |||
| 0.245 | 0.158 | 0.612 | GABA C receptor rho-3 antagonist | 0.612 0.006 DBMET00617 0.421 0.052 DBMET00946 | DBMET00617 | |
| 0.233 | 0.147 | 0.378 | Sodium/bile acid cotransporter inhibitor | 0.378 0.025 DBMET00946 | DBMET00946 | |
| 0.118 | 0.032 | 0.118 | Polo-like kinase-1 inhibitor | 0.084 0.074 DBMET00617 0.103 0.043 DBMET00946 | ||
| 0.099 | 0.015 | 0.151 | Phospholipase D inhibitor | 0.108 0.01 DBMET00617 0.151 0.003 DBMET00946 | DBMET00946 | |
| 0.103 | 0.025 | 0.174 | GABA aminotransferase inhibitor | 0.174 0.005 DBMET00617 0.16 0.006 DBMET00946 | DBMET00617 | |
| 0.101 | 0.023 | 0.112 | Estrogen-related receptor beta agonist | 0.112 0.014 DBMET00617 0.107 0.017 DBMET00946 | DBMET00617 | |
| 0.13 | 0.058 | 0.176 | Proteasome inhibitor | 0.1 0.088 DBMET00617 0.176 0.034 DBMET00946 | DBMET00946 | |
| 0.148 | 0.079 | 0.631 | Peroxidase inhibitor | 0.631 0.004 DBMET00617 0.403 0.02 DBMET00946 | DBMET00617 | |
| 0.174 | 0.122 | 0.283 | 5 Hydroxytryptamine 3E antagonist | 0.283 0.007 DBMET00617 0.164 0.156 DBMET00946 | DBMET00617 | |
| 0.085 | 0.033 | 0.109 | Vanilloid 4 agonist | 0.109 0.011 DBMET00617 0.094 0.022 DBMET00946 | DBMET00617 | |
| 0.079 | 0.028 | 0.111 | Protease 3C (Human rhinovirus) inhibitor | 0.081 0.026 DBMET00617 0.111 0.012 DBMET00946 | DBMET00946 | |
| 0.106 | 0.056 | 0.144 | Factor V inhibitor | 0.144 0.021 DBMET00946 | DBMET00946 | |
| 0.091 | 0.043 | 0.105 | Chymotrypsin inhibitor | 0.105 0.033 DBMET00946 | DBMET00946 | |
| 0.093 | 0.046 | 0.174 | Granulocyte macrophage colony stimulating factor agonist | 0.142 0.007 DBMET00617 0.174 0.004 DBMET00946 | DBMET00946 | |
| 0.113 | 0.068 | 0.113 | Interleukin 1b antagonist | |||
| 0.061 | 0.018 | 0.061 | Factor X inhibitor | |||
| 0.078 | 0.041 | 0.09 | Potassium channel (Tandem pore domain) blocker | 0.084 0.027 DBMET00617 0.09 0.017 DBMET00946 | DBMET00946 | |
| 0.056 | 0.02 | 0.087 | Thymidylate synthase inhibitor | 0.054 0.023 DBMET00617 0.087 0.005 DBMET00946 | DBMET00946 | |
| 0.103 | 0.069 | 0.227 | DOPA decarboxylase inhibitor | 0.227 0.004 DBMET00617 0.154 0.019 DBMET00946 | DBMET00617 | |
| 0.034 | 0.004 | 0.034 | Estrogen-related receptor gamma agonist | 0.02 0.011 DBMET00946 | ||
| 0.181 | 0.152 | 0.387 | DNA synthesis inhibitor | 0.287 0.048 DBMET00617 0.387 0.023 DBMET00946 | DBMET00946 | |
| 0.075 | 0.047 | 0.237 | Aminopeptidase I inhibitor | 0.138 0.015 DBMET00617 0.237 0.005 DBMET00946 | DBMET00946 | |
| 0.034 | 0.007 | 0.034 | Bombesin agonist | |||
| 0.092 | 0.065 | 0.117 | Protein kinase C mu inhibitor | 0.117 0.043 DBMET00946 | DBMET00946 | |
| 0.035 | 0.01 | 0.035 | Protocollagen prolyl hydroxylase inhibitor | 0.032 0.013 DBMET00946 | ||
| 0.047 | 0.023 | 0.052 | Dihydrofolate reductase inhibitor | 0.052 0.016 DBMET00617 0.048 0.021 DBMET00946 | DBMET00617 | |
| 0.049 | 0.025 | 0.058 | Oxytocin agonist | 0.058 0.018 DBMET00617 0.054 0.021 DBMET00946 | DBMET00617 | |
| 0.06 | 0.038 | 0.068 | Cathepsin L inhibitor | 0.068 0.031 DBMET00946 | DBMET00946 | |
| 0.037 | 0.015 | 0.037 | Glucagon receptor antagonist | |||
| 0.056 | 0.034 | 0.095 | Myc inhibitor | 0.095 0.009 DBMET00946 | DBMET00946 | |
| 0.107 | 0.086 | 0.133 | Transcription factor STAT6 inhibitor | 0.124 0.053 DBMET00617 0.133 0.04 DBMET00946 | DBMET00946 | |
| 0.156 | 0.136 | 0.313 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.313 0.02 DBMET00617 0.262 0.037 DBMET00946 | DBMET00617 | |
| 0.072 | 0.054 | 0.144 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.144 0.004 DBMET00617 0.071 0.056 DBMET00946 | DBMET00617 | |
| 0.025 | 0.008 | 0.025 | Bombesin 3 receptor agonist | |||
| 0.198 | 0.18 | 0.44 | Antithrombotic | 0.312 0.081 DBMET00617 0.44 0.04 DBMET00946 | DBMET00946 | |
| 0.061 | 0.045 | 0.097 | Caspase 9 inhibitor | 0.097 0.015 DBMET00946 | DBMET00946 | |
| 0.14 | 0.125 | 0.333 | Psychostimulant | 0.3 0.043 DBMET00617 0.333 0.035 DBMET00946 | DBMET00946 | |
| 0.04 | 0.026 | 0.04 | Histone deacetylase class I inhibitor | |||
| 0.044 | 0.03 | 0.107 | AICAR transformylase inhibitor | 0.054 0.018 DBMET00617 0.107 0.004 DBMET00946 | DBMET00946 | |
| 0.04 | 0.027 | 0.04 | Cathepsin L1 inhibitor | 0.037 0.03 DBMET00946 | ||
| 0.053 | 0.041 | 0.065 | Epithelial sodium channel blocker | 0.064 0.024 DBMET00617 0.065 0.023 DBMET00946 | DBMET00946 | |
| 0.041 | 0.029 | 0.047 | Plasmepsin II inhibitor | 0.047 0.02 DBMET00617 0.047 0.02 DBMET00946 | DBMET00946 | |
| 0.045 | 0.034 | 0.045 | Baculoviral IAP repeat-containing protein inhibitor | 0.045 0.036 DBMET00946 | ||
| 0.167 | 0.156 | 0.568 | 5 Hydroxytryptamine release stimulant | 0.568 0.018 DBMET00617 0.291 0.073 DBMET00946 | DBMET00617 | |
| 0.028 | 0.017 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.02 DBMET00946 | ||
| 0.082 | 0.072 | 0.082 | Falcipain inhibitor | |||
| 0.033 | 0.025 | 0.033 | Calpain 1 inhibitor | |||
| 0.086 | 0.079 | 0.168 | Interleukin 1 beta converting enzyme inhibitor | 0.088 0.076 DBMET00617 0.168 0.012 DBMET00946 | DBMET00946 | |
| 0.024 | 0.017 | 0.024 | Histone deacetylase 3 inhibitor | |||
| 0.078 | 0.072 | 0.078 | Falcipain 2 inhibitor | |||
| 0.079 | 0.073 | 0.131 | 3C-Like protease (SARS coronavirus) inhibitor | 0.131 0.015 DBMET00946 | DBMET00946 | |
| 0.037 | 0.032 | 0.053 | Integrin alpha1beta1 antagonist | 0.053 0.006 DBMET00946 | DBMET00946 | |
| 0.082 | 0.078 | 0.121 | MAO A inhibitor | 0.121 0.052 DBMET00617 | DBMET00617 | |
| 0.174 | 0.173 | 0.269 | Neuropeptide Y2 antagonist | 0.269 0.039 DBMET00617 0.218 0.091 DBMET00946 | DBMET00617 | |
| 0.004 | 0.003 | 0.006 | Reverse transcriptase (HBV) inhibitor | 0.006 0.002 DBMET00946 | DBMET00946 | |
| 0.088 | 0.089 | 0.132 | Glutamate (mGluR7) agonist | 0.132 0.02 DBMET00617 0.107 0.047 DBMET00946 | DBMET00617 | |
| 0.049 | 0.05 | 0.063 | Cathepsin B inhibitor | 0.06 0.035 DBMET00617 0.063 0.033 DBMET00946 | DBMET00946 | |
| 0.095 | 0.097 | 0.136 | MAO inhibitor | 0.136 0.067 DBMET00617 | DBMET00617 | |
| 0.039 | 0.042 | 0.08 | Antimetabolite | 0.041 0.039 DBMET00617 0.08 0.019 DBMET00946 | DBMET00946 | |
| 0.053 | 0.056 | 0.117 | HIV-1 integrase (3'-Processing) inhibitor | 0.117 0.02 DBMET00617 0.06 0.047 DBMET00946 | DBMET00617 | |
| 0.025 | 0.028 | 0.052 | Peptide deformylase inhibitor | 0.052 0.009 DBMET00617 0.029 0.022 DBMET00946 | DBMET00617 | |
| 0.033 | 0.038 | 0.047 | Potassium channel Kv1.1 blocker | 0.047 0.015 DBMET00617 | DBMET00617 | |
| 0.025 | 0.03 | 0.047 | Purinergic P2Y15 antagonist | 0.047 0.004 DBMET00617 0.03 0.017 DBMET00946 | DBMET00617 | |
| 0.099 | 0.106 | 0.21 | Toll-Like receptor 2 antagonist | 0.153 0.051 DBMET00617 0.21 0.019 DBMET00946 | DBMET00946 | |
| 0.119 | 0.126 | 0.196 | Adenylate cyclase stimulant | 0.196 0.015 DBMET00617 0.16 0.047 DBMET00946 | DBMET00617 | |
| 0.03 | 0.037 | 0.052 | Factor XIIIa inhibitor | 0.052 0.015 DBMET00617 | DBMET00617 | |
| 0.025 | 0.033 | 0.038 | Plasma kallikrein inhibitor | 0.038 0.02 DBMET00946 | DBMET00946 | |
| 0.024 | 0.033 | 0.032 | Dipeptidyl peptidase I inhibitor | 0.032 0.019 DBMET00946 | DBMET00946 | |
| 0.017 | 0.027 | 0.033 | Protease (Human cytomegalovirus) inhibitor | 0.025 0.012 DBMET00617 0.033 0.006 DBMET00946 | DBMET00946 | |
| 0.088 | 0.097 | 0.109 | Nav1.4 sodium channel blocker | 0.109 0.063 DBMET00946 | DBMET00946 | |
| 0.088 | 0.098 | 0.271 | GABA C receptor antagonist | 0.271 0.005 DBMET00617 0.189 0.015 DBMET00946 | DBMET00617 | |
| 0.016 | 0.026 | 0.03 | Caspase 8 inhibitor | 0.03 0.005 DBMET00946 | DBMET00946 | |
| 0.017 | 0.028 | 0.026 | Aminopeptidase P inhibitor | 0.026 0.013 DBMET00946 | DBMET00946 | |
| 0.036 | 0.048 | 0.051 | Cathepsin F inhibitor | 0.051 0.012 DBMET00946 | DBMET00946 | |
| 0.043 | 0.057 | 0.061 | Adenosine A1 receptor antagonist | 0.061 0.039 DBMET00617 | DBMET00617 | |
| 0.077 | 0.092 | 0.128 | Sphingomyelinase inhibitor | 0.128 0.035 DBMET00617 0.103 0.056 DBMET00946 | DBMET00617 | |
| 0.049 | 0.064 | 0.06 | Cathepsin E inhibitor | 0.06 0.04 DBMET00946 | DBMET00946 | |
| 0.022 | 0.036 | 0.036 | Plasmepsin I inhibitor | 0.036 0.015 DBMET00946 | DBMET00946 | |
| 0.034 | 0.049 | 0.041 | Sphingosine kinase 1 inhibitor | 0.041 0.029 DBMET00617 | DBMET00617 | |
| 0.041 | 0.057 | 0.059 | Cathepsin D inhibitor | 0.059 0.035 DBMET00946 | DBMET00946 | |
| 0.029 | 0.045 | 0.065 | Integrin alpha2 antagonist | 0.039 0.022 DBMET00617 0.065 0.006 DBMET00946 | DBMET00946 | |
| 0.049 | 0.065 | 0.069 | Immunoglobulin Fc receptor antagonist | 0.069 0.012 DBMET00617 0.058 0.029 DBMET00946 | DBMET00617 | |
| 0.082 | 0.1 | 0.281 | Carbonic anhydrase XV inhibitor | 0.281 0.009 DBMET00617 0.228 0.014 DBMET00946 | DBMET00617 | |
| 0.084 | 0.102 | 0.253 | Adenylate cyclase inhibitor | 0.124 0.064 DBMET00617 0.253 0.019 DBMET00946 | DBMET00946 | |
| 0.016 | 0.034 | 0.019 | Follicle-stimulating hormone antagonist | 0.019 0.015 DBMET00946 | DBMET00946 | |
| 0.028 | 0.048 | 0.044 | Erythropoietin receptor agonist | 0.044 0.025 DBMET00946 | DBMET00946 | |
| 0.026 | 0.046 | 0.049 | Complement C3a chemotactic receptor antagonist | 0.049 0.027 DBMET00946 | DBMET00946 | |
| 0.039 | 0.059 | 0.054 | Human rhinovirus A protease inhibitor | 0.054 0.039 DBMET00946 | DBMET00946 | |
| 0.166 | 0.186 | 0.355 | Transcription factor STAT3 inhibitor | 0.252 0.082 DBMET00617 0.355 0.031 DBMET00946 | DBMET00946 | |
| 0.048 | 0.069 | 0.063 | Sphingosine kinase inhibitor | 0.063 0.034 DBMET00617 0.062 0.036 DBMET00946 | DBMET00617 | |
| 0.002 | 0.023 | 0.006 | Bone morphogenic protein 1 inhibitor | 0.006 0.004 DBMET00946 | DBMET00946 | |
| 0.075 | 0.096 | 0.149 | Urease inhibitor | 0.149 0.024 DBMET00617 0.132 0.034 DBMET00946 | DBMET00617 | |
| 0.046 | 0.067 | 0.103 | Sphingosine 1-phosphate receptor 3 antagonist | 0.059 0.04 DBMET00617 0.103 0.007 DBMET00946 | DBMET00946 | |
| 0.034 | 0.056 | 0.061 | Ribonucleoside-diphosphate reductase inhibitor | 0.061 0.034 DBMET00617 0.06 0.034 DBMET00946 | DBMET00617 | |
| 0.033 | 0.056 | 0.438 | Dihydroorotase inhibitor | 0.049 0.026 DBMET00617 0.438 0.002 DBMET00946 | DBMET00946 | |
| 0.014 | 0.037 | 0.022 | Elastase 2A inhibitor | 0.022 0.015 DBMET00946 | DBMET00946 | |
| 0.014 | 0.037 | 0.022 | Elastase 2 inhibitor | 0.022 0.015 DBMET00946 | DBMET00946 | |
| 0.055 | 0.078 | 0.264 | Glutamate decarboxylase inhibitor | 0.264 0.004 DBMET00617 0.239 0.005 DBMET00946 | DBMET00617 | |
| 0.022 | 0.044 | 0.043 | Calcitonin receptor agonist | 0.033 0.024 DBMET00617 0.043 0.019 DBMET00946 | DBMET00946 | |
| 0.041 | 0.064 | 0.104 | HIV-1 integrase (Strand Transfer) inhibitor | 0.104 0.021 DBMET00617 | DBMET00617 | |
| 0.022 | 0.046 | 0.031 | Glucosylceramidase stimulant | 0.031 0.011 DBMET00617 | DBMET00617 | |
| 0.038 | 0.062 | 0.046 | Collagenase inhibitor | 0.046 0.041 DBMET00946 | DBMET00946 | |
| 0.034 | 0.058 | 0.062 | Ribonucleotide reductase inhibitor | 0.062 0.035 DBMET00617 0.061 0.036 DBMET00946 | DBMET00617 | |
| 0.023 | 0.048 | 0.087 | Cathepsin L2 inhibitor | 0.087 0.009 DBMET00946 | DBMET00946 | |
| 0.033 | 0.058 | 0.046 | Kallikrein inhibitor | 0.046 0.035 DBMET00946 | DBMET00946 | |
| 0.009 | 0.035 | 0.037 | Integrin alpha4beta7 antagonist | 0.037 0.007 DBMET00946 | DBMET00946 | |
| 0.068 | 0.094 | 0.098 | MAP kinase kinase 7 inhibitor | 0.098 0.015 DBMET00617 0.097 0.015 DBMET00946 | DBMET00617 | |
| 0.028 | 0.055 | 0.055 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.013 DBMET00617 0.055 0.004 DBMET00946 | DBMET00946 | |
| 0.155 | 0.181 | 0.244 | Peptidyltransferase inhibitor | 0.244 0.055 DBMET00946 | DBMET00946 | |
| 0.156 | 0.183 | 0.261 | 5 Hydroxytryptamine 1E antagonist | 0.261 0.063 DBMET00617 | DBMET00617 | |
| 0.015 | 0.043 | 0.055 | Neuraminidase (Influenza B) inhibitor | 0.025 0.008 DBMET00617 0.055 0.002 DBMET00946 | DBMET00946 | |
| 0.107 | 0.135 | 0.159 | Sphingosine 1-phosphate receptor 2 antagonist | 0.157 0.032 DBMET00617 0.159 0.03 DBMET00946 | DBMET00946 | |
| 0.028 | 0.057 | 0.089 | Glutamate (mGluR1a) antagonist | 0.04 0.029 DBMET00617 0.089 0.006 DBMET00946 | DBMET00946 | |
| 0.042 | 0.073 | 0.077 | Carbonic anhydrase stimulant | 0.077 0.027 DBMET00617 0.066 0.035 DBMET00946 | DBMET00617 | |
| 0.04 | 0.07 | 0.081 | Lysine-specific demethylase 1A inhibitor | 0.081 0.012 DBMET00617 | DBMET00617 | |
| 0.075 | 0.106 | 0.396 | Ferrochelatase inhibitor | 0.388 0.004 DBMET00617 0.396 0.004 DBMET00946 | DBMET00946 | |
| 0.019 | 0.05 | 0.039 | Integrin alpha2beta1 antagonist | 0.028 0.015 DBMET00617 0.039 0.006 DBMET00946 | DBMET00946 | |
| 0.038 | 0.07 | 0.063 | HCV NS3/NS4A protease inhibitor | 0.05 0.032 DBMET00617 0.063 0.019 DBMET00946 | DBMET00946 | |
| 0.124 | 0.158 | 0.204 | ATPase inhibitor | 0.179 0.059 DBMET00617 0.204 0.034 DBMET00946 | DBMET00946 | |
| 0.043 | 0.077 | 0.073 | Botulinum neurotoxin type A inhibitor | 0.073 0.022 DBMET00617 | DBMET00617 | |
| 0.051 | 0.087 | 0.065 | Histone deacetylase SIRT3 inhibitor | 0.065 0.037 DBMET00617 0.06 0.048 DBMET00946 | DBMET00617 | |
| 0.073 | 0.109 | 0.53 | GABA C receptor agonist | 0.53 0.003 DBMET00617 0.378 0.006 DBMET00946 | DBMET00617 | |
| 0.021 | 0.058 | 0.037 | Somatostatin 1 antagonist | 0.037 0.028 DBMET00946 | DBMET00946 | |
| 0.026 | 0.065 | 0.04 | Delayed rectifier potassium channel blocker | 0.04 0.021 DBMET00617 | DBMET00617 | |
| 0.03 | 0.069 | 0.049 | Metalloproteinase-3 inhibitor | 0.049 0.034 DBMET00946 | DBMET00946 | |
| 0.041 | 0.081 | 0.064 | Cyclin A1 inhibitor | 0.064 0.031 DBMET00617 | DBMET00617 | |
| 0.11 | 0.15 | 0.274 | GABA C receptor rho-2 antagonist | 0.274 0.008 DBMET00617 0.187 0.037 DBMET00946 | DBMET00617 | |
| 0.122 | 0.163 | 0.271 | 3C-like protease (Human coronavirus) inhibitor | 0.207 0.048 DBMET00617 0.271 0.019 DBMET00946 | DBMET00946 | |
| 0.035 | 0.076 | 0.077 | Cannabinoid CB1 receptor agonist | 0.077 0.031 DBMET00946 | DBMET00946 | |
| 0.046 | 0.088 | 0.272 | Catalase inhibitor | 0.161 0.024 DBMET00617 0.272 0.007 DBMET00946 | DBMET00946 | |
| 0.032 | 0.074 | 0.061 | Histamine H1 receptor agonist | 0.061 0.008 DBMET00617 | DBMET00617 | |
| 0.065 | 0.108 | 0.113 | Protease inhibitor | 0.113 0.053 DBMET00946 | DBMET00946 | |
| 0.127 | 0.17 | 0.21 | Neurotensin receptor agonist | 0.179 0.05 DBMET00617 0.21 0.03 DBMET00946 | DBMET00946 | |
| 0.042 | 0.085 | 0.064 | Acetyl-CoA transferase 2 inhibitor | 0.064 0.024 DBMET00946 | DBMET00946 | |
| 0.035 | 0.079 | 0.067 | Prolyl endopeptidase inhibitor | 0.049 0.038 DBMET00617 0.067 0.018 DBMET00946 | DBMET00946 | |
| 0.025 | 0.07 | 0.072 | Membrane dipeptidase inhibitor | 0.055 0.013 DBMET00617 0.072 0.007 DBMET00946 | DBMET00946 | |
| 0.035 | 0.08 | 0.099 | Topoisomerase II beta inhibitor | 0.099 0.009 DBMET00617 0.055 0.026 DBMET00946 | DBMET00617 | |
| 0.007 | 0.053 | 0.021 | Integrin beta7 antagonist | 0.021 0.013 DBMET00946 | DBMET00946 | |
| 0.037 | 0.082 | 0.101 | Alpha-mannosidase inhibitor | 0.101 0.006 DBMET00617 0.061 0.025 DBMET00946 | DBMET00617 | |
| 0.036 | 0.081 | 0.062 | Bombesin 2 receptor antagonist | 0.05 0.034 DBMET00617 0.062 0.023 DBMET00946 | DBMET00946 | |
| 0.016 | 0.063 | 0.105 | Glutamate (mGluR1) agonist | 0.03 0.009 DBMET00617 0.105 0.004 DBMET00946 | DBMET00946 | |
| 0.018 | 0.065 | 0.047 | Epoxide hydrolase 1 inhibitor | 0.037 0.014 DBMET00617 0.047 0.007 DBMET00946 | DBMET00946 | |
| 0.132 | 0.179 | 0.203 | Histone acetyltransferase inhibitor | 0.202 0.066 DBMET00617 0.203 0.064 DBMET00946 | DBMET00946 | |
| 0.023 | 0.07 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.021 DBMET00617 0.037 0.022 DBMET00946 | DBMET00617 | |
| 0.082 | 0.13 | 0.117 | Calcium channel N-type blocker | 0.117 0.067 DBMET00946 | DBMET00946 | |
| 0.072 | 0.12 | 0.23 | GABA C receptor rho-1 antagonist | 0.23 0.005 DBMET00617 0.204 0.008 DBMET00946 | DBMET00617 | |
| 0.108 | 0.156 | 0.164 | Neuropeptide Y1 antagonist | 0.164 0.046 DBMET00617 0.152 0.062 DBMET00946 | DBMET00617 | |
| 0.046 | 0.094 | 0.075 | Elastase 1 inhibitor | 0.075 0.04 DBMET00946 | DBMET00946 | |
| 0.006 | 0.055 | 0.018 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.018 0.004 DBMET00617 | DBMET00617 | |
| 0.026 | 0.075 | 0.072 | Histamine H2 receptor agonist | 0.072 0.009 DBMET00617 | DBMET00617 | |
| 0.02 | 0.07 | 0.036 | Hedgehog signaling activator | 0.036 0.006 DBMET00617 | DBMET00617 | |
| 0.026 | 0.077 | 0.139 | Leukocyte elastase inhibitor | 0.139 0.006 DBMET00946 | DBMET00946 | |
| 0.038 | 0.089 | 0.073 | Sphingosine kinase 2 inhibitor | 0.073 0.019 DBMET00617 0.055 0.038 DBMET00946 | DBMET00617 | |
| 0.021 | 0.072 | 0.044 | Toll-Like receptor 2 agonist | 0.044 0.027 DBMET00617 0.04 0.03 DBMET00946 | DBMET00617 | |
| 0.026 | 0.078 | 0.037 | Adenosine uptake inhibitor | 0.037 0.019 DBMET00617 | DBMET00617 | |
| 0.109 | 0.161 | 0.165 | Melanin inhibitor | 0.16 0.069 DBMET00617 0.165 0.064 DBMET00946 | DBMET00946 | |
| 0.024 | 0.076 | 0.04 | Integrin alpha5beta1 antagonist | 0.04 0.029 DBMET00946 | DBMET00946 | |
| 0.006 | 0.059 | 0.023 | Aminopeptidase A inhibitor | 0.023 0.009 DBMET00946 | DBMET00946 | |
| 0.16 | 0.213 | 0.358 | Transcription factor STAT inhibitor | 0.242 0.093 DBMET00617 0.358 0.031 DBMET00946 | DBMET00946 | |
| 0.047 | 0.1 | 0.192 | Cathepsin G inhibitor | 0.099 0.034 DBMET00617 0.192 0.016 DBMET00946 | DBMET00946 | |
| 0.038 | 0.092 | 0.083 | Factor III inhibitor | 0.083 0.007 DBMET00946 | DBMET00946 | |
| 0.087 | 0.141 | 0.132 | Nav1.2 sodium channel blocker | 0.132 0.07 DBMET00946 | DBMET00946 | |
| 0.059 | 0.113 | 0.237 | Aminopeptidase B inhibitor | 0.18 0.027 DBMET00617 0.237 0.014 DBMET00946 | DBMET00946 | |
| 0.064 | 0.12 | 0.257 | Creatine kinase inhibitor | 0.21 0.009 DBMET00617 0.257 0.005 DBMET00946 | DBMET00946 | |
| 0.05 | 0.106 | 0.087 | Secretase beta inhibitor | 0.067 0.054 DBMET00617 0.087 0.028 DBMET00946 | DBMET00946 | |
| 0.018 | 0.074 | 0.062 | Carbonic anhydrase IV inhibitor | 0.062 0.018 DBMET00617 0.045 0.028 DBMET00946 | DBMET00617 | |
| 0.05 | 0.106 | 0.265 | Glutamate dehydrogenase inhibitor | 0.182 0.012 DBMET00617 0.265 0.007 DBMET00946 | DBMET00946 | |
| 0.017 | 0.074 | 0.041 | Lysophosphatidic acid 2 receptor antagonist | 0.034 0.017 DBMET00617 0.041 0.012 DBMET00946 | DBMET00946 | |
| 0.023 | 0.08 | 0.182 | Phosphorylase inhibitor | 0.182 0.005 DBMET00946 | DBMET00946 | |
| 0.012 | 0.07 | 0.036 | Lysine carboxypeptidase inhibitor | 0.033 0.013 DBMET00617 0.036 0.012 DBMET00946 | DBMET00946 | |
| 0.075 | 0.133 | 0.142 | Nav1.3 sodium channel blocker | 0.142 0.053 DBMET00946 | DBMET00946 | |
| 0.022 | 0.081 | 0.065 | Glutamate (mGluR3) agonist | 0.042 0.008 DBMET00617 0.065 0.003 DBMET00946 | DBMET00946 | |
| 0.041 | 0.1 | 0.152 | NMDA receptor agonist | 0.087 0.025 DBMET00617 0.152 0.008 DBMET00946 | DBMET00946 | |
| 0.014 | 0.074 | 0.034 | Lysophosphatidic acid receptor 1 agonist | 0.034 0.008 DBMET00617 0.032 0.009 DBMET00946 | DBMET00617 | |
| 0.157 | 0.218 | 0.338 | Transcription factor NF kappa B inhibitor | 0.266 0.116 DBMET00617 0.338 0.081 DBMET00946 | DBMET00946 | |
| 0.011 | 0.072 | 0.029 | Antibiotic Anthracycline-like | 0.029 0.004 DBMET00617 | DBMET00617 | |
| 0.006 | 0.067 | 0.012 | Integrin alphaLbeta2 antagonist | 0.012 0.011 DBMET00946 | DBMET00946 | |
| 0.102 | 0.163 | 0.306 | Hemostatic | 0.306 0.015 DBMET00946 | DBMET00946 | |
| 0.01 | 0.072 | 0.056 | Arginase inhibitor | 0.051 0.015 DBMET00617 0.056 0.012 DBMET00946 | DBMET00946 | |
| 0.032 | 0.094 | 0.06 | Potassium channel (ATP-sensitive) activator | 0.06 0.016 DBMET00617 0.056 0.02 DBMET00946 | DBMET00617 | |
| 0.014 | 0.076 | 0.029 | Caspase 2 inhibitor | 0.029 0.025 DBMET00946 | DBMET00946 | |
| 0.004 | 0.068 | 0.017 | Adenosine A2a receptor agonist | 0.017 0.009 DBMET00617 | DBMET00617 | |
| 0.034 | 0.097 | 0.063 | Potassium channel (Inward rectifier) activator | 0.063 0.016 DBMET00617 0.059 0.021 DBMET00946 | DBMET00617 | |
| 0.011 | 0.075 | 0.028 | Acetylcholine M4 receptor agonist | 0.028 0.023 DBMET00617 | DBMET00617 | |
| 0.067 | 0.131 | 0.107 | Hematopoietic | 0.107 0.03 DBMET00946 | DBMET00946 | |
| 0.028 | 0.093 | 0.185 | Acyl-CoA dehydrogenase inhibitor | 0.185 0.006 DBMET00617 0.16 0.008 DBMET00946 | DBMET00617 | |
| 0.039 | 0.105 | 0.069 | DNA helicase inhibitor | 0.069 0.018 DBMET00946 | DBMET00946 | |
| 0.004 | 0.07 | 0.017 | Thrombopoietin agonist | 0.017 0.004 DBMET00946 | DBMET00946 | |
| 0.049 | 0.116 | 0.068 | Beta 2 adrenoreceptor agonist | 0.06 0.051 DBMET00617 0.068 0.023 DBMET00946 | DBMET00946 | |
| 0.021 | 0.089 | 0.034 | Cholecystokinin B agonist | 0.034 0.032 DBMET00946 | DBMET00946 | |
| 0.067 | 0.135 | 0.204 | Anesthetic local | 0.092 0.091 DBMET00617 0.204 0.031 DBMET00946 | DBMET00946 | |
| 0.03 | 0.099 | 0.04 | CF transmembrane conductance regulator antagonist | 0.04 0.026 DBMET00617 | DBMET00617 | |
| 0.047 | 0.116 | 0.059 | Trypsin inhibitor | 0.059 0.05 DBMET00946 | DBMET00946 | |
| 0.004 | 0.073 | 0.021 | Lysophosphatidic acid receptor 3 agonist | 0.021 0.005 DBMET00617 0.013 0.01 DBMET00946 | DBMET00617 | |
| 0.182 | 0.252 | 0.335 | Antibacterial | 0.312 0.126 DBMET00617 0.335 0.111 DBMET00946 | DBMET00946 | |
| 0.007 | 0.077 | 0.017 | Adenosine A2 receptor agonist | 0.017 0.01 DBMET00617 | DBMET00617 | |
| 0.095 | 0.167 | 0.136 | Vanilloid 1 agonist | 0.136 0.056 DBMET00617 0.119 0.09 DBMET00946 | DBMET00617 | |
| 0.014 | 0.085 | 0.032 | ICAM 1 antagonist | 0.026 0.01 DBMET00617 0.032 0.005 DBMET00946 | DBMET00946 | |
| 0.113 | 0.185 | 0.727 | Aldehyde oxidase inhibitor | 0.727 0.006 DBMET00617 0.627 0.015 DBMET00946 | DBMET00617 | |
| 0.011 | 0.084 | 0.063 | Endothelial nitric-oxide synthase inhibitor | 0.063 0.007 DBMET00617 | DBMET00617 | |
| 0.014 | 0.087 | 0.036 | Vanilloid 2 agonist | 0.036 0.005 DBMET00617 0.03 0.01 DBMET00946 | DBMET00617 | |
| 0.065 | 0.137 | 0.116 | D-Ala-D-Ala ligase inhibitor | 0.116 0.016 DBMET00617 0.115 0.016 DBMET00946 | DBMET00617 | |
| 0.057 | 0.13 | 0.097 | Potassium channel activator | 0.097 0.051 DBMET00946 | DBMET00946 | |
| 0.002 | 0.076 | 0.01 | DNA topoisomerase III inhibitor | 0.01 0.004 DBMET00617 | DBMET00617 | |
| 0.018 | 0.092 | 0.087 | Dihydropteroate synthase inhibitor | 0.087 0.005 DBMET00617 0.065 0.01 DBMET00946 | DBMET00617 | |
| 0.025 | 0.1 | 0.039 | Neurotensin receptor antagonist | 0.039 0.038 DBMET00946 | DBMET00946 | |
| 0.022 | 0.097 | 0.153 | Ornithine carbamoyltransferase inhibitor | 0.11 0.014 DBMET00617 0.153 0.009 DBMET00946 | DBMET00946 | |
| 0.073 | 0.148 | 0.185 | Caspase 3 inhibitor | 0.101 0.09 DBMET00617 0.185 0.013 DBMET00946 | DBMET00946 | |
| 0.069 | 0.146 | 0.214 | Mucolytic | 0.141 0.038 DBMET00617 0.214 0.01 DBMET00946 | DBMET00946 | |
| 0.057 | 0.135 | 0.165 | Prolactin inhibitor | 0.165 0.017 DBMET00617 0.097 0.058 DBMET00946 | DBMET00617 | |
| 0.056 | 0.135 | 0.107 | Glutathione S-transferase inhibitor | 0.085 0.054 DBMET00617 0.107 0.031 DBMET00946 | DBMET00946 | |
| 0.027 | 0.106 | 0.919 | Maillard reaction inhibitor | 0.919 0 DBMET00617 | DBMET00617 | |
| 0.022 | 0.101 | 0.09 | Mannosidase inhibitor | 0.09 0.007 DBMET00617 0.056 0.02 DBMET00946 | DBMET00617 | |
| 0.017 | 0.096 | 0.035 | Estrogen-related receptor gamma antagonist | 0.035 0.008 DBMET00617 | DBMET00617 | |
| 0.013 | 0.093 | 0.037 | Methionyl aminopeptidase 1 inhibitor | 0.033 0.02 DBMET00617 0.037 0.015 DBMET00946 | DBMET00946 | |
| 0.018 | 0.098 | 0.031 | Dipeptidyl peptidase II inhibitor | 0.031 0.026 DBMET00617 | DBMET00617 | |
| 0.097 | 0.178 | 0.165 | LIM domain kinase 1 inhibitor | 0.165 0.084 DBMET00617 0.148 0.099 DBMET00946 | DBMET00617 | |
| 0.071 | 0.153 | 0.27 | Adenylate kinase inhibitor | 0.27 0.009 DBMET00617 0.223 0.012 DBMET00946 | DBMET00617 | |
| 0.015 | 0.097 | 0.025 | Myristoyl transferase inhibitor | 0.025 0.024 DBMET00617 | DBMET00617 | |
| 0.047 | 0.129 | 0.068 | Metalloproteinase-9 inhibitor | 0.068 0.059 DBMET00617 0.067 0.061 DBMET00946 | DBMET00617 | |
| 0.011 | 0.095 | 0.017 | Tryptophan hydroxylase 1 inhibitor | 0.017 0.013 DBMET00946 | DBMET00946 | |
| 0.045 | 0.13 | 0.063 | HIV-1 integrase inhibitor | 0.063 0.062 DBMET00946 | DBMET00946 | |
| 0.07 | 0.156 | 0.187 | Microtubule formation inhibitor | 0.142 0.042 DBMET00617 0.187 0.023 DBMET00946 | DBMET00946 | |
| 0.008 | 0.095 | 0.06 | Methionyl aminopeptidase 2 inhibitor | 0.026 0.017 DBMET00617 0.06 0.005 DBMET00946 | DBMET00946 | |
| 0.026 | 0.114 | 0.067 | Kainate receptor agonist | 0.067 0.005 DBMET00617 0.06 0.007 DBMET00946 | DBMET00617 | |
| 0.005 | 0.093 | 0.057 | Integrin alpha4 antagonist | 0.057 0.01 DBMET00946 | DBMET00946 | |
| 0.041 | 0.13 | 0.091 | MAO B inhibitor | 0.091 0.065 DBMET00617 | DBMET00617 | |
| 0.009 | 0.098 | 0.039 | Nicotinic alpha4beta2 receptor agonist | 0.039 0.008 DBMET00617 | DBMET00617 | |
| 0.005 | 0.093 | 0.054 | VLA-4 antagonist | 0.054 0.012 DBMET00946 | DBMET00946 | |
| 0.034 | 0.123 | 0.064 | Nicotinic alpha3beta2 receptor antagonist | 0.064 0.022 DBMET00617 0.05 0.043 DBMET00946 | DBMET00617 | |
| 0.169 | 0.258 | 0.217 | Transcription factor inhibitor | 0.217 0.212 DBMET00617 | DBMET00617 | |
| 0.014 | 0.104 | 0.031 | Acid ceramidase inhibitor | 0.031 0.008 DBMET00617 | DBMET00617 | |
| 0.053 | 0.143 | 0.241 | Alcohol dehydrogenase inhibitor | 0.108 0.044 DBMET00617 0.241 0.008 DBMET00946 | DBMET00946 | |
| 0.018 | 0.109 | 0.071 | Carbonic anhydrase II inhibitor | 0.071 0.029 DBMET00617 | DBMET00617 | |
| 0.025 | 0.117 | 0.088 | Adenylate cyclase 1 inhibitor | 0.088 0.005 DBMET00617 | DBMET00617 | |
| 0.044 | 0.136 | 0.082 | Metalloproteinase-2 inhibitor | 0.082 0.051 DBMET00946 | DBMET00946 | |
| 0.022 | 0.116 | 0.035 | HCV polyprotein inhibitor | 0.035 0.02 DBMET00946 | DBMET00946 | |
| 0.043 | 0.137 | 0.076 | Beta 3 adrenoreceptor antagonist | 0.062 0.05 DBMET00617 0.076 0.027 DBMET00946 | DBMET00946 | |
| 0.026 | 0.12 | 0.079 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.072 0.004 DBMET00617 0.079 0.004 DBMET00946 | DBMET00946 | |
| 0.005 | 0.1 | 0.024 | Cyclin T1 inhibitor | 0.024 0.008 DBMET00617 | DBMET00617 | |
| 0.007 | 0.102 | 0.019 | Complement factor D inhibitor | 0.019 0.012 DBMET00617 | DBMET00617 | |
| 0.06 | 0.156 | 0.171 | Nitric-oxide synthase inhibitor | 0.171 0.016 DBMET00617 | DBMET00617 | |
| 0.034 | 0.13 | 0.353 | Histidine decarboxylase inhibitor | 0.353 0.005 DBMET00617 0.288 0.007 DBMET00946 | DBMET00617 | |
| 0.056 | 0.153 | 0.079 | Factor XII inhibitor | 0.079 0.068 DBMET00946 | DBMET00946 | |
| 0.102 | 0.199 | 0.142 | MAP kinase 3 inhibitor | 0.137 0.09 DBMET00617 0.142 0.082 DBMET00946 | DBMET00946 | |
| 0.041 | 0.138 | 0.09 | Epoxide hydrolase inhibitor | 0.09 0.032 DBMET00946 | DBMET00946 | |
| 0.023 | 0.121 | 0.067 | Neutrophil collagenase inhibitor | 0.067 0.042 DBMET00617 0.058 0.053 DBMET00946 | DBMET00617 | |
| 0.109 | 0.206 | 0.154 | Focal adhesion kinase 2 inhibitor | 0.154 0.124 DBMET00617 0.154 0.125 DBMET00946 | DBMET00946 | |
| 0.008 | 0.107 | 0.115 | 5-Alpha-reductase 2 inhibitor | 0.115 0.005 DBMET00946 | DBMET00946 | |
| 0.017 | 0.116 | 0.071 | Carbonic anhydrase I inhibitor | 0.071 0.029 DBMET00617 | DBMET00617 | |
| 0.03 | 0.131 | 0.082 | Collagenase 3 inhibitor | 0.082 0.023 DBMET00946 | DBMET00946 | |
| 0.032 | 0.134 | 0.061 | Dipeptidyl peptidase inhibitor | 0.061 0.025 DBMET00617 | DBMET00617 | |
| 0.02 | 0.122 | 0.083 | Carbonic anhydrase inhibitor | 0.083 0.033 DBMET00617 | DBMET00617 | |
| 0.007 | 0.109 | 0.039 | Cholecystokinin A antagonist | 0.039 0.025 DBMET00946 | DBMET00946 | |
| 0.035 | 0.138 | 0.063 | Angiotensin-converting enzyme inhibitor | 0.063 0.026 DBMET00946 | DBMET00946 | |
| 0.004 | 0.108 | 0.015 | Integrin beta2 antagonist | 0.015 0.007 DBMET00946 | DBMET00946 | |
| 0.023 | 0.129 | 0.786 | Alcohol oxidase inhibitor | 0.786 0.003 DBMET00617 0.244 0.005 DBMET00946 | DBMET00617 | |
| 0.02 | 0.126 | 0.08 | Carbonic anhydrase XIV inhibitor | 0.08 0.017 DBMET00617 0.063 0.023 DBMET00946 | DBMET00617 | |
| 0.023 | 0.129 | 0.214 | Argininosuccinate synthase inhibitor | 0.165 0.01 DBMET00617 0.214 0.007 DBMET00946 | DBMET00946 | |
| 0.009 | 0.116 | 0.032 | Lysophosphatidic acid 1 receptor antagonist | 0.032 0.005 DBMET00946 | DBMET00946 | |
| 0.025 | 0.132 | 0.049 | Glucagon-like peptide 1 receptor antagonist | 0.049 0.014 DBMET00946 | DBMET00946 | |
| 0.01 | 0.117 | 0.139 | 5-Alpha-reductase inhibitor | 0.139 0.007 DBMET00946 | DBMET00946 | |
| 0.011 | 0.12 | 0.072 | LFA antagonist | 0.072 0.004 DBMET00946 | DBMET00946 | |
| 0.05 | 0.159 | 0.099 | Sphingosine 1-phosphate receptor antagonist | 0.099 0.022 DBMET00946 | DBMET00946 | |
| 0.056 | 0.165 | 0.247 | NADH dehydrogenase inhibitor | 0.247 0.008 DBMET00617 0.225 0.009 DBMET00946 | DBMET00617 | |
| 0.033 | 0.144 | 0.056 | 5 Hydroxytryptamine 7 agonist | 0.056 0.038 DBMET00617 | DBMET00617 | |
| 0.011 | 0.123 | 0.023 | Methylmalonyl-CoA mutase inhibitor | 0.023 0.005 DBMET00617 0.021 0.007 DBMET00946 | DBMET00617 | |
| 0.025 | 0.138 | 0.208 | Carbamoyl phosphate synthetase inhibitor | 0.208 0.007 DBMET00617 0.084 0.026 DBMET00946 | DBMET00617 | |
| 0.004 | 0.116 | 0.037 | Carbonic anhydrase X inhibitor | 0.037 0.004 DBMET00617 0.02 0.008 DBMET00946 | DBMET00617 | |
| 0.004 | 0.116 | 0.037 | Carbonic anhydrase VIII inhibitor | 0.037 0.004 DBMET00617 0.02 0.008 DBMET00946 | DBMET00617 | |
| 0.016 | 0.129 | 0.064 | Geranyltranstransferase inhibitor | 0.064 0.011 DBMET00617 0.059 0.014 DBMET00946 | DBMET00617 | |
| 0.086 | 0.199 | 0.122 | Aurora-C kinase inhibitor | 0.122 0.102 DBMET00946 | DBMET00946 | |
| 0.025 | 0.137 | 0.063 | CC chemokine 2 receptor antagonist | 0.063 0.029 DBMET00946 | DBMET00946 | |
| 0.115 | 0.227 | 0.188 | Ca2+-transporting ATPase inhibitor | 0.188 0.005 DBMET00617 0.174 0.01 DBMET00946 | DBMET00617 | |
| 0.102 | 0.215 | 0.328 | Immunostimulant | 0.255 0.094 DBMET00617 0.328 0.071 DBMET00946 | DBMET00946 | |
| 0.006 | 0.12 | 0.025 | Telomerase stimulant | 0.025 0.004 DBMET00617 | DBMET00617 | |
| 0.025 | 0.141 | 0.063 | 5 Hydroxytryptamine 2A agonist | 0.063 0.044 DBMET00617 | DBMET00617 | |
| 0.022 | 0.139 | 0.086 | Lysophosphatidic acid 3 receptor antagonist | 0.068 0.016 DBMET00617 0.086 0.008 DBMET00946 | DBMET00946 | |
| 0.048 | 0.167 | 0.084 | Histamine H2 receptor antagonist | 0.084 0.057 DBMET00617 | DBMET00617 | |
| 0.023 | 0.142 | 0.055 | Beta 2 adrenoreceptor antagonist | 0.055 0.029 DBMET00946 | DBMET00946 | |
| 0.008 | 0.127 | 0.051 | Glutamate (mGluR1a) agonist | 0.051 0.005 DBMET00617 0.032 0.008 DBMET00946 | DBMET00617 | |
| 0.003 | 0.123 | 0.018 | Carbonic anhydrase XI inhibitor | 0.018 0.005 DBMET00617 | DBMET00617 | |
| 0.023 | 0.143 | 0.102 | NMDA receptor glycine site agonist | 0.092 0.021 DBMET00617 0.102 0.016 DBMET00946 | DBMET00946 | |
| 0.036 | 0.157 | 0.076 | Corticotropin releasing factor 2 receptor antagonist | 0.076 0.02 DBMET00617 | DBMET00617 | |
| 0.031 | 0.152 | 0.266 | Porphobilinogen synthase inhibitor | 0.266 0.007 DBMET00617 0.252 0.008 DBMET00946 | DBMET00617 | |
| 0.027 | 0.148 | 0.058 | Cytokine production stimulant | 0.058 0.015 DBMET00617 | DBMET00617 | |
| 0.063 | 0.185 | 0.14 | Glutamate release inhibitor | 0.14 0.012 DBMET00617 0.106 0.035 DBMET00946 | DBMET00617 | |
| 0.033 | 0.154 | 0.078 | Beta adrenoreceptor antagonist | 0.069 0.04 DBMET00617 0.078 0.029 DBMET00946 | DBMET00946 | |
| 0.04 | 0.163 | 0.149 | Myeloperoxidase inhibitor | 0.149 0.011 DBMET00617 | DBMET00617 | |
| 0.114 | 0.237 | 0.166 | Heat shock protein 70 antagonist | 0.156 0.034 DBMET00617 0.166 0.021 DBMET00946 | DBMET00946 | |
| 0.061 | 0.184 | 0.104 | CC chemokine 5 receptor agonist | 0.104 0.018 DBMET00617 | DBMET00617 | |
| 0.025 | 0.148 | 0.04 | VCAM antagonist | 0.04 0.024 DBMET00946 | DBMET00946 | |
| 0.025 | 0.148 | 0.04 | VCAM-1 antagonist | 0.04 0.024 DBMET00946 | DBMET00946 | |
| 0.011 | 0.135 | 0.074 | Integrin antagonist | 0.074 0.021 DBMET00946 | DBMET00946 | |
| 0.01 | 0.135 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.025 0.007 DBMET00617 | DBMET00617 | |
| 0.024 | 0.149 | 0.049 | Matrix metalloproteinase (membrane-type) inhibitor | 0.049 0.048 DBMET00617 | DBMET00617 | |
| 0.039 | 0.164 | 0.155 | Ornithine decarboxylase inhibitor | 0.137 0.016 DBMET00617 0.155 0.01 DBMET00946 | DBMET00946 | |
| 0.052 | 0.177 | 0.122 | Chelator | 0.122 0.052 DBMET00946 | DBMET00946 | |
| 0.005 | 0.131 | 0.027 | Cholecystokinin B antagonist | 0.027 0.025 DBMET00946 | DBMET00946 | |
| 0.005 | 0.133 | 0.07 | 5-Alpha-reductase 1 inhibitor | 0.07 0.006 DBMET00946 | DBMET00946 | |
| 0.005 | 0.134 | 0.018 | Nicotinic alpha4 receptor agonist | 0.018 0.009 DBMET00617 | DBMET00617 | |
| 0.019 | 0.149 | 0.057 | Nerve growth factor antagonist | 0.057 0.011 DBMET00617 0.054 0.014 DBMET00946 | DBMET00617 | |
| 0.023 | 0.153 | 0.226 | Biliverdin reductase inhibitor | 0.197 0.006 DBMET00617 0.226 0.005 DBMET00946 | DBMET00946 | |
| 0.002 | 0.133 | 0.019 | Glutamate (mGluR6) agonist | 0.019 0.004 DBMET00617 0.014 0.006 DBMET00946 | DBMET00617 | |
| 0.014 | 0.146 | 0.045 | Angiotensin II receptor antagonist | 0.035 0.023 DBMET00617 0.045 0.009 DBMET00946 | DBMET00946 | |
| 0.028 | 0.16 | 0.055 | Beta adrenoreceptor agonist | 0.055 0.012 DBMET00946 | DBMET00946 | |
| 0.022 | 0.154 | 0.067 | Beta 1 adrenoreceptor antagonist | 0.066 0.03 DBMET00617 0.067 0.029 DBMET00946 | DBMET00946 | |
| 0.054 | 0.186 | 0.131 | Lanosterol 14 alpha demethylase inhibitor | 0.131 0.021 DBMET00617 0.113 0.038 DBMET00946 | DBMET00617 | |
| 0.051 | 0.183 | 0.36 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.257 0.009 DBMET00617 0.36 0.004 DBMET00946 | DBMET00946 | |
| 0.011 | 0.143 | 0.129 | TRPM8 blocker | 0.129 0.005 DBMET00946 | DBMET00946 | |
| 0.027 | 0.16 | 0.061 | Squalene epoxidase inhibitor | 0.061 0.019 DBMET00617 | DBMET00617 | |
| 0.052 | 0.185 | 0.143 | Anabolic | 0.143 0.022 DBMET00617 0.113 0.046 DBMET00946 | DBMET00617 | |
| 0.007 | 0.141 | 0.049 | Cholecystokinin antagonist | 0.049 0.025 DBMET00946 | DBMET00946 | |
| 0.011 | 0.146 | 0.044 | Calcium-sensing receptor agonist | 0.044 0.006 DBMET00946 | DBMET00946 | |
| 0.021 | 0.156 | 0.067 | Elastase inhibitor | 0.067 0.024 DBMET00946 | DBMET00946 | |
| 0.013 | 0.15 | 0.054 | NMDA 2A receptor antagonist | 0.054 0.034 DBMET00946 | DBMET00946 | |
| 0.019 | 0.156 | 0.083 | Neuraminidase (Influenza A) inhibitor | 0.083 0.005 DBMET00946 | DBMET00946 | |
| 0.017 | 0.154 | 0.037 | Melatonin receptor 1A agonist | 0.037 0.017 DBMET00617 | DBMET00617 | |
| 0.008 | 0.145 | 0.03 | Beta 1 adrenoreceptor agonist | 0.03 0.008 DBMET00946 | DBMET00946 | |
| 0.002 | 0.139 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET00617 | DBMET00617 | |
| 0.001 | 0.14 | 0.007 | CC chemokine 6 receptor agonist | 0.007 0.004 DBMET00617 | DBMET00617 | |
| 0.055 | 0.194 | 0.205 | Electrolyte absorption antagonist | 0.176 0.012 DBMET00617 0.205 0.008 DBMET00946 | DBMET00946 | |
| 0.014 | 0.155 | 0.056 | Angiotensin AT1 receptor antagonist | 0.048 0.021 DBMET00617 0.056 0.01 DBMET00946 | DBMET00946 | |
| 0.015 | 0.157 | 0.109 | RNA-directed RNA polymerase inhibitor | 0.031 0.03 DBMET00617 0.109 0.005 DBMET00946 | DBMET00946 | |
| 0.045 | 0.188 | 0.2 | Expectorant | 0.112 0.056 DBMET00617 0.2 0.02 DBMET00946 | DBMET00946 | |
| 0.03 | 0.173 | 0.163 | CD45 antagonist | 0.163 0.005 DBMET00946 | DBMET00946 | |
| 0.078 | 0.223 | 0.129 | Heat shock protein 90 antagonist | 0.129 0.099 DBMET00617 | DBMET00617 | |
| 0.01 | 0.155 | 0.083 | Fumarate hydratase inhibitor | 0.083 0.007 DBMET00617 0.057 0.011 DBMET00946 | DBMET00617 | |
| 0.078 | 0.224 | 0.188 | Hexokinase inhibitor | 0.161 0.066 DBMET00617 0.188 0.043 DBMET00946 | DBMET00946 | |
| 0.095 | 0.241 | 0.314 | Spasmolytic | 0.241 0.095 DBMET00617 0.314 0.065 DBMET00946 | DBMET00946 | |
| 0.049 | 0.196 | 0.272 | Triose-phosphate isomerase inhibitor | 0.267 0.006 DBMET00617 0.272 0.006 DBMET00946 | DBMET00946 | |
| 0.016 | 0.164 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.031 0.01 DBMET00617 | DBMET00617 | |
| 0.033 | 0.181 | 0.066 | Aryl hydrocarbon receptor antagonist | 0.066 0.044 DBMET00617 | DBMET00617 | |
| 0.013 | 0.161 | 0.056 | Glutamate (mGluR group I) agonist | 0.056 0.026 DBMET00946 | DBMET00946 | |
| 0.101 | 0.251 | 0.211 | Phospholipase C inhibitor | 0.194 0.048 DBMET00617 0.211 0.037 DBMET00946 | DBMET00946 | |
| 0.058 | 0.208 | 0.264 | Thrombolytic | 0.264 0.03 DBMET00946 | DBMET00946 | |
| 0.003 | 0.153 | 0.017 | Human herpes virus 5 capsid protein P40 inhibitor | 0.017 0.005 DBMET00617 | DBMET00617 | |
| 0.031 | 0.18 | 0.156 | Purinergic P2X1 antagonist | 0.118 0.012 DBMET00617 0.156 0.006 DBMET00946 | DBMET00946 | |
| 0.024 | 0.174 | 0.107 | Glucose-6-phosphate isomerase inhibitor | 0.107 0.004 DBMET00617 0.048 0.033 DBMET00946 | DBMET00617 | |
| 0.007 | 0.159 | 0.097 | HCV NS5B polymerase inhibitor | 0.097 0.005 DBMET00946 | DBMET00946 | |
| 0.02 | 0.172 | 0.073 | Glutamate (mGluR8) agonist | 0.073 0.005 DBMET00617 0.062 0.006 DBMET00946 | DBMET00617 | |
| 0.031 | 0.185 | 0.07 | Heat shock protein 90 beta antagonist | 0.07 0.029 DBMET00617 0.057 0.046 DBMET00946 | DBMET00617 | |
| 0.08 | 0.236 | 0.158 | DNA repair enzyme inhibitor | 0.158 0.025 DBMET00617 0.113 0.087 DBMET00946 | DBMET00617 | |
| 0.02 | 0.176 | 0.05 | Thymidine kinase inhibitor | 0.05 0.019 DBMET00617 | DBMET00617 | |
| 0.015 | 0.172 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.027 DBMET00617 | DBMET00617 | |
| 0.014 | 0.171 | 0.034 | Complement factor 1s inhibitor | 0.034 0.005 DBMET00617 | DBMET00617 | |
| 0.025 | 0.183 | 0.168 | Phenylalanine 4-hydroxylase inhibitor | 0.157 0.011 DBMET00617 0.168 0.009 DBMET00946 | DBMET00946 | |
| 0.009 | 0.168 | 0.038 | Nicotinic acid receptor 2 antagonist | 0.037 0.006 DBMET00617 0.038 0.005 DBMET00946 | DBMET00946 | |
| 0.022 | 0.181 | 0.153 | Aconitate hydratase inhibitor | 0.137 0.005 DBMET00617 0.153 0.004 DBMET00946 | DBMET00946 | |
| 0.004 | 0.164 | 0.021 | Thromboxane A2 agonist | 0.021 0.005 DBMET00617 | DBMET00617 | |
| 0.007 | 0.17 | 0.042 | Prostacyclin antagonist | 0.042 0.017 DBMET00946 | DBMET00946 | |
| 0.007 | 0.17 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 DBMET00617 | DBMET00617 | |
| 0.065 | 0.228 | 0.164 | Histone deacetylase SIRT1 inhibitor | 0.164 0.051 DBMET00946 | DBMET00946 | |
| 0.012 | 0.176 | 0.089 | Dopamine D5 agonist | 0.089 0.005 DBMET00617 | DBMET00617 | |
| 0.076 | 0.24 | 0.102 | Sphingosine 1-phosphate receptor 2 agonist | 0.102 0.095 DBMET00946 | DBMET00946 | |
| 0.044 | 0.209 | 0.316 | UDP-glucose 4-epimerase inhibitor | 0.316 0.009 DBMET00617 0.262 0.012 DBMET00946 | DBMET00617 | |
| 0.076 | 0.243 | 0.315 | DNA methyltransferase I inhibitor | 0.247 0.048 DBMET00617 0.315 0.021 DBMET00946 | DBMET00946 | |
| 0.028 | 0.196 | 0.06 | Sphingosine 1-phosphate receptor 1 antagonist | 0.06 0.029 DBMET00946 | DBMET00946 | |
| 0.03 | 0.201 | 0.089 | Thrombin inhibitor | 0.089 0.033 DBMET00617 | DBMET00617 | |
| 0.022 | 0.194 | 0.051 | Dipeptidyl peptidase IV inhibitor | 0.051 0.019 DBMET00617 | DBMET00617 | |
| 0.092 | 0.264 | 0.302 | Succinate dehydrogenase inhibitor | 0.302 0.01 DBMET00617 0.291 0.012 DBMET00946 | DBMET00617 | |
| 0.007 | 0.182 | 0.045 | AMPA 3 receptor antagonist | 0.045 0.011 DBMET00946 | DBMET00946 | |
| 0.078 | 0.254 | 0.304 | DNA methylase inhibitor | 0.238 0.055 DBMET00617 0.304 0.026 DBMET00946 | DBMET00946 | |
| 0.019 | 0.197 | 0.075 | Glucagon-like peptide 1 agonist | 0.075 0.038 DBMET00946 | DBMET00946 | |
| 0.027 | 0.205 | 0.128 | CYP2A6 inhibitor | 0.128 0.023 DBMET00617 | DBMET00617 | |
| 0.005 | 0.183 | 0.075 | Carbonic anhydrase IX inhibitor | 0.075 0.03 DBMET00617 | DBMET00617 | |
| 0.004 | 0.182 | 0.025 | Alpha 2a adrenoreceptor agonist | 0.025 0.007 DBMET00617 | DBMET00617 | |
| 0.002 | 0.182 | 0.017 | Angiotensin AT1B receptor antagonist | 0.017 0.007 DBMET00946 | DBMET00946 | |
| 0.003 | 0.184 | 0.044 | AMPA 1 receptor antagonist | 0.044 0.013 DBMET00946 | DBMET00946 | |
| 0.039 | 0.219 | 0.116 | Glutamate (mGluR6) antagonist | 0.114 0.007 DBMET00617 0.116 0.006 DBMET00946 | DBMET00946 | |
| 0.068 | 0.249 | 0.215 | Arachidonic acid antagonist | 0.215 0.021 DBMET00617 0.164 0.072 DBMET00946 | DBMET00617 | |
| 0.017 | 0.198 | 0.037 | Protein kinase (CK2) beta inhibitor | 0.037 0.016 DBMET00617 0.037 0.016 DBMET00946 | DBMET00946 | |
| 0.031 | 0.213 | 0.055 | 5 Hydroxytryptamine 5A antagonist | 0.055 0.054 DBMET00617 | DBMET00617 | |
| 0.015 | 0.198 | 0.05 | Plasminogen activator inhibitor | 0.05 0.048 DBMET00946 | DBMET00946 | |
| 0.044 | 0.226 | 0.102 | GABA B receptor agonist | 0.102 0.015 DBMET00617 0.079 0.044 DBMET00946 | DBMET00617 | |
| 0.006 | 0.188 | 0.02 | Purinergic P2Y1 agonist | 0.02 0.007 DBMET00617 | DBMET00617 | |
| 0.037 | 0.222 | 0.109 | Exportin-1 inhibitor | 0.109 0.006 DBMET00617 | DBMET00617 | |
| 0.023 | 0.209 | 0.067 | Thromboxane synthase inhibitor | 0.054 0.039 DBMET00617 0.067 0.02 DBMET00946 | DBMET00946 | |
| 0.01 | 0.196 | 0.029 | Thyroid hormone agonist | 0.029 0.013 DBMET00617 | DBMET00617 | |
| 0.021 | 0.209 | 0.064 | Androgen agonist | 0.064 0.036 DBMET00617 | DBMET00617 | |
| 0.005 | 0.193 | 0.058 | Carbonic anhydrase XII inhibitor | 0.058 0.034 DBMET00617 | DBMET00617 | |
| 0.03 | 0.218 | 0.207 | Potassium channel (Ca-activated) activator | 0.133 0.034 DBMET00617 0.207 0.013 DBMET00946 | DBMET00946 | |
| 0.077 | 0.266 | 0.344 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.344 0.052 DBMET00617 0.152 0.14 DBMET00946 | DBMET00617 | |
| 0.027 | 0.218 | 0.064 | Potassium channel (ATP-sensitive) blocker | 0.064 0.052 DBMET00617 | DBMET00617 | |
| 0.064 | 0.255 | 0.337 | Diuretic | 0.16 0.069 DBMET00617 0.337 0.018 DBMET00946 | DBMET00946 | |
| 0.041 | 0.232 | 0.313 | Cystathionine beta-synthase inhibitor | 0.313 0.009 DBMET00617 0.171 0.032 DBMET00946 | DBMET00617 | |
| 0.003 | 0.195 | 0.053 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.053 0.008 DBMET00617 | DBMET00617 | |
| 0.116 | 0.307 | 0.255 | Alpha-glucosidase inhibitor | 0.255 0.184 DBMET00617 | DBMET00617 | |
| 0.035 | 0.228 | 0.062 | Bcl-xL inhibitor | 0.062 0.033 DBMET00946 | DBMET00946 | |
| 0.026 | 0.22 | 0.066 | Sirtuin 1 inhibitor | 0.066 0.05 DBMET00946 | DBMET00946 | |
| 0.01 | 0.205 | 0.081 | Alpha 1d adrenoreceptor agonist | 0.081 0.005 DBMET00617 | DBMET00617 | |
| 0.003 | 0.197 | 0.014 | Egl nine homolog 3 inhibitor | 0.011 0.009 DBMET00617 0.014 0.006 DBMET00946 | DBMET00946 | |
| 0.023 | 0.219 | 0.105 | Na+ K+ transporting ATPase inhibitor | 0.105 0.027 DBMET00617 | DBMET00617 | |
| 0.021 | 0.217 | 0.139 | Carbonic anhydrase VA inhibitor | 0.139 0.013 DBMET00617 0.06 0.059 DBMET00946 | DBMET00617 | |
| 0.055 | 0.251 | 0.271 | Aldehyde dehydrogenase inhibitor | 0.271 0.015 DBMET00617 0.205 0.026 DBMET00946 | DBMET00617 | |
| 0.017 | 0.214 | 0.098 | Prostaglandin-E synthase inhibitor | 0.098 0.028 DBMET00946 | DBMET00946 | |
| 0.075 | 0.271 | 0.13 | Growth hormone agonist | 0.13 0.107 DBMET00946 | DBMET00946 | |
| 0.043 | 0.241 | 0.135 | Bile acid receptor antagonist | 0.097 0.056 DBMET00617 0.135 0.011 DBMET00946 | DBMET00946 | |
| 0.072 | 0.272 | 0.269 | MAP kinase kinase 2 inhibitor | 0.269 0.046 DBMET00617 0.14 0.13 DBMET00946 | DBMET00617 | |
| 0.045 | 0.245 | 0.106 | MAP kinase kinase 1 inhibitor | 0.104 0.052 DBMET00617 0.106 0.049 DBMET00946 | DBMET00946 | |
| 0.029 | 0.229 | 0.059 | Phosphodiesterase 1A inhibitor | 0.059 0.044 DBMET00617 | DBMET00617 | |
| 0.003 | 0.204 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.01 DBMET00617 | DBMET00617 | |
| 0.017 | 0.217 | 0.205 | Phosphofructokinase-1 inhibitor | 0.205 0.011 DBMET00617 0.118 0.026 DBMET00946 | DBMET00617 | |
| 0.043 | 0.245 | 0.131 | Protein kinase C gamma inhibitor | 0.131 0.044 DBMET00617 0.126 0.048 DBMET00946 | DBMET00617 | |
| 0.007 | 0.209 | 0.082 | Vascular adhesion protein 1 inhibitor | 0.082 0.005 DBMET00617 | DBMET00617 | |
| 0.009 | 0.212 | 0.033 | MAP3K8 inhibitor | 0.033 0.013 DBMET00617 | DBMET00617 | |
| 0.009 | 0.213 | 0.023 | Factor XIII inhibitor | 0.023 0.01 DBMET00617 | DBMET00617 | |
| 0.003 | 0.208 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.012 DBMET00617 | DBMET00617 | |
| 0.011 | 0.217 | 0.054 | Thromboxane A2 antagonist | 0.054 0.033 DBMET00946 | DBMET00946 | |
| 0.043 | 0.25 | 0.099 | Beta glucuronidase inhibitor | 0.099 0.071 DBMET00617 | DBMET00617 | |
| 0.007 | 0.214 | 0.046 | Phosphoglycerate kinase inhibitor | 0.046 0.016 DBMET00617 | DBMET00617 | |
| 0.018 | 0.227 | 0.151 | Carbonic anhydrase V inhibitor | 0.151 0.014 DBMET00617 | DBMET00617 | |
| 0.004 | 0.213 | 0.022 | Nicotinic acid receptor 1 antagonist | 0.022 0.007 DBMET00617 0.02 0.009 DBMET00946 | DBMET00617 | |
| 0.026 | 0.235 | 0.101 | Calcium antagonist | 0.101 0.047 DBMET00617 | DBMET00617 | |
| 0.016 | 0.229 | 0.043 | 5 Hydroxytryptamine 2B agonist | 0.043 0.02 DBMET00617 | DBMET00617 | |
| 0.03 | 0.244 | 0.119 | Adrenaline agonist | 0.119 0.026 DBMET00946 | DBMET00946 | |
| 0.04 | 0.254 | 0.084 | Protein kinase C zeta inhibitor | 0.084 0.078 DBMET00617 | DBMET00617 | |
| 0.037 | 0.252 | 0.159 | HIV-1 integrase (Overall Integration) inhibitor | 0.159 0.022 DBMET00617 0.101 0.054 DBMET00946 | DBMET00617 | |
| 0.019 | 0.234 | 0.071 | Protein kinase C beta inhibitor | 0.071 0.046 DBMET00617 0.068 0.052 DBMET00946 | DBMET00617 | |
| 0.042 | 0.257 | 0.131 | Histone deacetylase class III inhibitor | 0.131 0.06 DBMET00946 | DBMET00946 | |
| 0.166 | 0.381 | 0.458 | Caspase 9 stimulant | 0.458 0.079 DBMET00617 0.311 0.182 DBMET00946 | DBMET00617 | |
| 0.008 | 0.226 | 0.057 | Carbonic anhydrase VII inhibitor | 0.057 0.021 DBMET00617 0.041 0.039 DBMET00946 | DBMET00617 | |
| 0.019 | 0.237 | 0.05 | CC chemokine 4 receptor antagonist | 0.05 0.027 DBMET00617 | DBMET00617 | |
| 0.055 | 0.275 | 0.281 | Pyruvate kinase inhibitor | 0.281 0.053 DBMET00617 0.142 0.122 DBMET00946 | DBMET00617 | |
| 0.029 | 0.25 | 0.131 | Histamine N-methyltransferase inhibitor | 0.131 0.023 DBMET00617 | DBMET00617 | |
| 0.043 | 0.269 | 0.165 | Carbonic anhydrase III inhibitor | 0.133 0.036 DBMET00617 0.165 0.023 DBMET00946 | DBMET00946 | |
| 0.062 | 0.288 | 0.247 | Insulin sensitizer | 0.168 0.11 DBMET00617 0.247 0.036 DBMET00946 | DBMET00946 | |
| 0.013 | 0.239 | 0.056 | Thromboxane antagonist | 0.056 0.035 DBMET00946 | DBMET00946 | |
| 0.031 | 0.258 | 0.078 | Adenosine A3 receptor antagonist | 0.078 0.046 DBMET00617 | DBMET00617 | |
| 0.025 | 0.252 | 0.08 | Dihydroorotate oxidase inhibitor | 0.08 0.01 DBMET00617 0.074 0.014 DBMET00946 | DBMET00617 | |
| 0.033 | 0.261 | 0.096 | Peroxisome proliferator-activated receptor gamma antagonist | 0.096 0.017 DBMET00946 | DBMET00946 | |
| 0.028 | 0.257 | 0.159 | Inducible nitric-oxide synthase inhibitor | 0.159 0.014 DBMET00617 | DBMET00617 | |
| 0.01 | 0.24 | 0.078 | Factor XIa inhibitor | 0.078 0.008 DBMET00946 | DBMET00946 | |
| 0.091 | 0.323 | 0.201 | 12-Lipoxygenase inhibitor | 0.201 0.15 DBMET00946 | DBMET00946 | |
| 0.02 | 0.253 | 0.065 | Cyclin D1 inhibitor | 0.065 0.035 DBMET00617 | DBMET00617 | |
| 0.056 | 0.29 | 0.221 | Cell wall synthesis inhibitor | 0.221 0.023 DBMET00617 0.213 0.025 DBMET00946 | DBMET00617 | |
| 0.006 | 0.24 | 0.043 | Carnitine palmitoyltransferase inhibitor | 0.033 0.025 DBMET00617 0.043 0.013 DBMET00946 | DBMET00946 | |
| 0.051 | 0.284 | 0.105 | NADPH oxidase inhibitor | 0.105 0.104 DBMET00617 | DBMET00617 | |
| 0.076 | 0.311 | 0.191 | CF transmembrane conductance regulator agonist | 0.191 0.027 DBMET00617 0.13 0.117 DBMET00946 | DBMET00617 | |
| 0.015 | 0.251 | 0.082 | Selectin antagonist | 0.082 0.035 DBMET00946 | DBMET00946 | |
| 0.018 | 0.254 | 0.087 | Sphingosine 1-phosphate receptor 4 agonist | 0.087 0.032 DBMET00617 | DBMET00617 | |
| 0.06 | 0.296 | 0.205 | Mannose-6-phosphate isomerase inhibitor | 0.205 0.028 DBMET00617 0.137 0.077 DBMET00946 | DBMET00617 | |
| 0.013 | 0.249 | 0.061 | Adenosine deaminase inhibitor | 0.061 0.02 DBMET00617 0.061 0.02 DBMET00946 | DBMET00946 | |
| 0.027 | 0.263 | 0.106 | Glutamate (mGluR7) antagonist | 0.106 0.008 DBMET00617 0.063 0.057 DBMET00946 | DBMET00617 | |
| 0.008 | 0.246 | 0.043 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.043 0.014 DBMET00617 | DBMET00617 | |
| 0.005 | 0.245 | 0.03 | Cyclin E2 inhibitor | 0.03 0.019 DBMET00617 | DBMET00617 | |
| 0.017 | 0.257 | 0.153 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.153 0.008 DBMET00617 | DBMET00617 | |
| 0.008 | 0.249 | 0.161 | Carbonic anhydrase VB inhibitor | 0.161 0.008 DBMET00617 | DBMET00617 | |
| 0.015 | 0.258 | 0.076 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.053 0.049 DBMET00617 0.076 0.027 DBMET00946 | DBMET00946 | |
| 0.005 | 0.248 | 0.014 | Cyclin D2 inhibitor | 0.014 0.007 DBMET00617 | DBMET00617 | |
| 0.049 | 0.292 | 0.152 | Photosensitizer | 0.152 0.03 DBMET00617 0.118 0.06 DBMET00946 | DBMET00617 | |
| 0.009 | 0.253 | 0.062 | NMDA 2C receptor antagonist | 0.056 0.051 DBMET00617 0.062 0.042 DBMET00946 | DBMET00946 | |
| 0.052 | 0.296 | 0.148 | TRPA1 agonist | 0.125 0.053 DBMET00617 0.148 0.032 DBMET00946 | DBMET00946 | |
| 0.016 | 0.261 | 0.056 | Purinergic P2X2 antagonist | 0.056 0.054 DBMET00946 | DBMET00946 | |
| 0.118 | 0.364 | 0.523 | Histamine release inhibitor | 0.404 0.073 DBMET00617 0.523 0.022 DBMET00946 | DBMET00946 | |
| 0.077 | 0.324 | 0.229 | Neurotrophic factor enhancer | 0.229 0.052 DBMET00617 | DBMET00617 | |
| 0.017 | 0.264 | 0.096 | Nicotinic alpha4beta2 receptor antagonist | 0.096 0.035 DBMET00617 | DBMET00617 | |
| 0.015 | 0.263 | 0.089 | Diacylglycerol O-acyltransferase inhibitor | 0.089 0.011 DBMET00946 | DBMET00946 | |
| 0.031 | 0.279 | 0.197 | Carbonic anhydrase VI inhibitor | 0.197 0.013 DBMET00617 0.097 0.041 DBMET00946 | DBMET00617 | |
| 0.007 | 0.255 | 0.042 | Carnitine palmitoyltransferase 1 inhibitor | 0.034 0.024 DBMET00617 0.042 0.014 DBMET00946 | DBMET00946 | |
| 0.01 | 0.259 | 0.05 | Thymidine phosphorylase inhibitor | 0.05 0.005 DBMET00617 | DBMET00617 | |
| 0.019 | 0.268 | 0.143 | Monophenol monooxygenase inhibitor | 0.143 0.05 DBMET00617 0.118 0.062 DBMET00946 | DBMET00617 | |
| 0.005 | 0.257 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.021 DBMET00617 | DBMET00617 | |
| 0.04 | 0.292 | 0.1 | Bromodomain-containing protein 2 inhibitor | 0.1 0.04 DBMET00617 | DBMET00617 | |
| 0.05 | 0.303 | 0.134 | Acetylcholine release stimulant | 0.134 0.03 DBMET00617 | DBMET00617 | |
| 0.056 | 0.31 | 0.156 | Heat shock protein 90 alpha antagonist | 0.124 0.121 DBMET00617 0.156 0.081 DBMET00946 | DBMET00946 | |
| 0.014 | 0.268 | 0.066 | Cyclin-dependent kinase 6 inhibitor | 0.066 0.035 DBMET00617 | DBMET00617 | |
| 0.03 | 0.284 | 0.084 | Caspase 7 inhibitor | 0.084 0.053 DBMET00617 | DBMET00617 | |
| 0.025 | 0.28 | 0.072 | Glucosylceramidase inhibitor | 0.072 0.02 DBMET00617 | DBMET00617 | |
| 0.007 | 0.263 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.023 DBMET00617 | DBMET00617 | |
| 0.006 | 0.263 | 0.047 | Prostaglandin EP4 antagonist | 0.047 0.009 DBMET00946 | DBMET00946 | |
| 0.003 | 0.26 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 DBMET00617 | DBMET00617 | |
| 0.002 | 0.261 | 0.017 | Egl nine homolog 1 inhibitor | 0.017 0.008 DBMET00946 | DBMET00946 | |
| 0.047 | 0.306 | 0.253 | Angiogenesis stimulant | 0.253 0.068 DBMET00946 | DBMET00946 | |
| 0.021 | 0.282 | 0.076 | Fatty acid synthase inhibitor | 0.076 0.021 DBMET00617 | DBMET00617 | |
| 0.027 | 0.287 | 0.078 | Interferon inducer | 0.078 0.025 DBMET00617 | DBMET00617 | |
| 0.003 | 0.265 | 0.023 | NMDA receptor glycine site antagonist | 0.023 0.019 DBMET00617 | DBMET00617 | |
| 0.031 | 0.294 | 0.122 | Glycine receptor agonist | 0.122 0.012 DBMET00617 0.092 0.026 DBMET00946 | DBMET00617 | |
| 0.005 | 0.268 | 0.042 | Factor XI inhibitor | 0.042 0.015 DBMET00946 | DBMET00946 | |
| 0.093 | 0.356 | 0.45 | Cholesterol antagonist | 0.319 0.079 DBMET00617 0.45 0.04 DBMET00946 | DBMET00946 | |
| 0.005 | 0.268 | 0.045 | Nicotinic alpha3beta4 receptor agonist | 0.045 0.007 DBMET00617 | DBMET00617 | |
| 0.012 | 0.276 | 0.099 | Acetylcholine M5 receptor agonist | 0.099 0.021 DBMET00617 | DBMET00617 | |
| 0.047 | 0.312 | 0.177 | Cyclooxygenase 3 inhibitor | 0.154 0.045 DBMET00617 0.177 0.029 DBMET00946 | DBMET00946 | |
| 0.007 | 0.271 | 0.023 | Retinoid X beta receptor antagonist | 0.022 0.011 DBMET00617 0.023 0.009 DBMET00946 | DBMET00946 | |
| 0.007 | 0.272 | 0.03 | 5 Hydroxytryptamine 6 agonist | 0.03 0.017 DBMET00617 | DBMET00617 | |
| 0.019 | 0.284 | 0.077 | Glutamate (mGluR4) antagonist | 0.053 0.018 DBMET00617 0.077 0.009 DBMET00946 | DBMET00946 | |
| 0.005 | 0.271 | 0.037 | Kainate receptor 2 antagonist | 0.033 0.028 DBMET00617 0.037 0.024 DBMET00946 | DBMET00946 | |
| 0.048 | 0.315 | 0.19 | Phospholipase A2 inhibitor | 0.176 0.056 DBMET00617 0.19 0.048 DBMET00946 | DBMET00946 | |
| 0.018 | 0.285 | 0.047 | Purinergic P2X4 antagonist | 0.047 0.03 DBMET00617 | DBMET00617 | |
| 0.016 | 0.283 | 0.051 | Leukotriene B4 antagonist | 0.051 0.042 DBMET00946 | DBMET00946 | |
| 0.036 | 0.305 | 0.174 | Alkaline phosphatase inhibitor | 0.174 0.045 DBMET00617 0.112 0.097 DBMET00946 | DBMET00617 | |
| 0.031 | 0.302 | 0.192 | Keratolytic | 0.102 0.029 DBMET00617 0.192 0.009 DBMET00946 | DBMET00946 | |
| 0.04 | 0.312 | 0.111 | mTOR complex 2 inhibitor | 0.111 0.023 DBMET00617 | DBMET00617 | |
| 0.016 | 0.288 | 0.042 | Glutamate (mGluR group III) agonist | 0.042 0.031 DBMET00617 0.04 0.034 DBMET00946 | DBMET00617 | |
| 0.003 | 0.277 | 0.019 | Alpha 2c adrenoreceptor agonist | 0.019 0.013 DBMET00617 | DBMET00617 | |
| 0.009 | 0.283 | 0.052 | GABA uptake inhibitor | 0.052 0.014 DBMET00617 0.039 0.028 DBMET00946 | DBMET00617 | |
| 0.025 | 0.3 | 0.093 | Interferon agonist | 0.093 0.035 DBMET00617 | DBMET00617 | |
| 0.02 | 0.296 | 0.064 | Heparanase inhibitor | 0.055 0.033 DBMET00617 0.064 0.018 DBMET00946 | DBMET00946 | |
| 0.005 | 0.282 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 DBMET00617 | DBMET00617 | |
| 0.006 | 0.29 | 0.075 | Glutamate (mGluR1) antagonist | 0.075 0.027 DBMET00617 | DBMET00617 | |
| 0.046 | 0.33 | 0.144 | Protein kinase stimulant | 0.144 0.072 DBMET00617 0.124 0.089 DBMET00946 | DBMET00617 | |
| 0.047 | 0.333 | 0.123 | Interleukin 8 antagonist | 0.11 0.076 DBMET00617 0.123 0.058 DBMET00946 | DBMET00946 | |
| 0.011 | 0.297 | 0.128 | Neuraminidase inhibitor | 0.128 0.009 DBMET00946 | DBMET00946 | |
| 0.027 | 0.315 | 0.108 | Potassium channel large-conductance Ca-activated activator | 0.108 0.02 DBMET00946 | DBMET00946 | |
| 0.013 | 0.301 | 0.039 | Retinoid X alpha receptor antagonist | 0.036 0.021 DBMET00617 0.039 0.016 DBMET00946 | DBMET00946 | |
| 0.006 | 0.294 | 0.042 | DNA gyrase subunit B inhibitor | 0.042 0.02 DBMET00617 | DBMET00617 | |
| 0.023 | 0.312 | 0.126 | Glycine receptor antagonist | 0.126 0.015 DBMET00617 | DBMET00617 | |
| 0.004 | 0.292 | 0.049 | Uridine phosphorylase inhibitor | 0.049 0.008 DBMET00617 | DBMET00617 | |
| 0.002 | 0.292 | 0.026 | Kainate receptor 1 antagonist | 0.026 0.012 DBMET00946 | DBMET00946 | |
| 0.072 | 0.362 | 0.313 | Cyclic AMP phosphodiesterase inhibitor | 0.313 0.037 DBMET00617 0.169 0.124 DBMET00946 | DBMET00617 | |
| 0.012 | 0.302 | 0.043 | AMPA 4 receptor antagonist | 0.039 0.028 DBMET00617 0.043 0.022 DBMET00946 | DBMET00946 | |
| 0.035 | 0.325 | 0.149 | Nav1.6 sodium channel blocker | 0.149 0.056 DBMET00617 | DBMET00617 | |
| 0.02 | 0.312 | 0.151 | Carbonic anhydrase XIII inhibitor | 0.151 0.021 DBMET00617 0.069 0.059 DBMET00946 | DBMET00617 | |
| 0.031 | 0.323 | 0.206 | 5 Hydroxytryptamine 3A agonist | 0.206 0.013 DBMET00617 | DBMET00617 | |
| 0.053 | 0.346 | 0.137 | Sphingosine 1-phosphate receptor 4 antagonist | 0.137 0.046 DBMET00617 0.132 0.052 DBMET00946 | DBMET00617 | |
| 0.004 | 0.297 | 0.053 | Kainate receptor antagonist | 0.044 0.026 DBMET00617 0.053 0.019 DBMET00946 | DBMET00946 | |
| 0.091 | 0.385 | 0.131 | CC chemokine 6 receptor antagonist | 0.131 0.065 DBMET00946 | DBMET00946 | |
| 0.091 | 0.388 | 0.462 | Vasodilator, peripheral | 0.462 0.037 DBMET00617 0.34 0.078 DBMET00946 | DBMET00617 | |
| 0.022 | 0.32 | 0.074 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.074 0.024 DBMET00617 | DBMET00617 | |
| 0.002 | 0.3 | 0.012 | Imidazoline I2 receptor antagonist | 0.012 0.006 DBMET00617 | DBMET00617 | |
| 0.013 | 0.314 | 0.045 | Retinoid X receptor antagonist | 0.04 0.023 DBMET00617 0.045 0.018 DBMET00946 | DBMET00946 | |
| 0.027 | 0.328 | 0.073 | Ryanodine receptor antagonist | 0.073 0.014 DBMET00617 | DBMET00617 | |
| 0.042 | 0.345 | 0.215 | Cell adhesion inhibitor | 0.215 0.021 DBMET00946 | DBMET00946 | |
| 0.004 | 0.308 | 0.049 | Somatostatin 5 antagonist | 0.049 0.013 DBMET00946 | DBMET00946 | |
| 0.027 | 0.334 | 0.102 | MAP kinase kinase inhibitor | 0.1 0.095 DBMET00617 0.102 0.093 DBMET00946 | DBMET00946 | |
| 0.021 | 0.327 | 0.076 | Pregnane X receptor antagonist | 0.076 0.009 DBMET00617 0.06 0.032 DBMET00946 | DBMET00617 | |
| 0.048 | 0.355 | 0.127 | Cyclin-dependent kinase 8 inhibitor | 0.127 0.106 DBMET00617 | DBMET00617 | |
| 0.011 | 0.321 | 0.072 | Alpha 2 adrenoreceptor agonist | 0.072 0.03 DBMET00617 | DBMET00617 | |
| 0.004 | 0.314 | 0.032 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.032 0.015 DBMET00617 | DBMET00617 | |
| 0.015 | 0.327 | 0.132 | Neuraminidase (influenza) inhibitor | 0.132 0.009 DBMET00946 | DBMET00946 | |
| 0.037 | 0.35 | 0.073 | Calcium channel P-type blocker | 0.073 0.023 DBMET00617 | DBMET00617 | |
| 0.024 | 0.338 | 0.122 | Mediator release inhibitor | 0.122 0.046 DBMET00946 | DBMET00946 | |
| 0.04 | 0.355 | 0.196 | Anticoagulant | 0.196 0.055 DBMET00946 | DBMET00946 | |
| 0.011 | 0.327 | 0.032 | Glutamate (mGluR4) agonist | 0.032 0.027 DBMET00617 | DBMET00617 | |
| 0.005 | 0.321 | 0.048 | Potassium channel small-conductance Ca-activated activator | 0.048 0.012 DBMET00617 | DBMET00617 | |
| 0.004 | 0.323 | 0.028 | Imidazoline I1 receptor antagonist | 0.028 0.008 DBMET00617 | DBMET00617 | |
| 0.006 | 0.327 | 0.046 | Retinoid X alpha receptor agonist | 0.034 0.025 DBMET00617 0.046 0.016 DBMET00946 | DBMET00946 | |
| 0.021 | 0.342 | 0.196 | M17 leucyl aminopeptidase inhibitor | 0.196 0.034 DBMET00946 | DBMET00946 | |
| 0.004 | 0.326 | 0.045 | Retinoid X receptor agonist | 0.045 0.02 DBMET00946 | DBMET00946 | |
| 0.025 | 0.35 | 0.093 | Gastric antisecretory | 0.093 0.075 DBMET00617 | DBMET00617 | |
| 0.028 | 0.353 | 0.127 | Cell adhesion molecule inhibitor | 0.127 0.021 DBMET00946 | DBMET00946 | |
| 0.017 | 0.342 | 0.054 | Aldosterone antagonist | 0.054 0.024 DBMET00617 | DBMET00617 | |
| 0.001 | 0.329 | 0.009 | Progesterone receptor A antagonist | 0.009 0.008 DBMET00617 | DBMET00617 | |
| 0.008 | 0.337 | 0.052 | Glutamate (mGluR3) antagonist | 0.047 0.014 DBMET00617 0.052 0.012 DBMET00946 | DBMET00946 | |
| 0.038 | 0.369 | 0.143 | Acetylcholine M1 receptor antagonist | 0.143 0.082 DBMET00617 | DBMET00617 | |
| 0.032 | 0.363 | 0.077 | Transcription factor RelA inhibitor | 0.077 0.02 DBMET00617 | DBMET00617 | |
| 0.053 | 0.385 | 0.186 | Antipruritic | 0.186 0.059 DBMET00946 | DBMET00946 | |
| 0.049 | 0.382 | 0.211 | Free radical scavenger | 0.211 0.089 DBMET00617 | DBMET00617 | |
| 0.016 | 0.352 | 0.067 | Dopamine beta hydroxylase inhibitor | 0.067 0.01 DBMET00617 | DBMET00617 | |
| 0.012 | 0.35 | 0.061 | Alpha adrenoreceptor agonist | 0.061 0.054 DBMET00617 | DBMET00617 | |
| 0.061 | 0.401 | 0.185 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.185 0.028 DBMET00946 | DBMET00946 | |
| 0.031 | 0.371 | 0.145 | Xanthine oxidase inhibitor | 0.145 0.036 DBMET00617 0.142 0.037 DBMET00946 | DBMET00617 | |
| 0.006 | 0.347 | 0.024 | Prostaglandin F2 alpha agonist | 0.024 0.013 DBMET00617 | DBMET00617 | |
| 0.003 | 0.345 | 0.02 | Adenosine kinase inhibitor | 0.02 0.017 DBMET00617 | DBMET00617 | |
| 0.007 | 0.351 | 0.084 | Nicotinic acid receptor agonist | 0.032 0.031 DBMET00617 0.084 0.006 DBMET00946 | DBMET00946 | |
| 0.068 | 0.414 | 0.176 | Sphingosine 1-phosphate receptor 5 antagonist | 0.17 0.034 DBMET00617 0.176 0.027 DBMET00946 | DBMET00946 | |
| 0.039 | 0.385 | 0.097 | Transcription factor NF kappa B stimulant | 0.097 0.042 DBMET00946 | DBMET00946 | |
| 0.004 | 0.352 | 0.043 | Farnesoid X receptor agonist | 0.043 0.021 DBMET00946 | DBMET00946 | |
| 0.022 | 0.37 | 0.129 | Cholesterol synthesis inhibitor | 0.129 0.057 DBMET00617 0.119 0.066 DBMET00946 | DBMET00617 | |
| 0.007 | 0.358 | 0.056 | CDK5/p25 inhibitor | 0.056 0.017 DBMET00617 | DBMET00617 | |
| 0.009 | 0.361 | 0.101 | Dihydroorotate dehydrogenase inhibitor | 0.101 0.011 DBMET00946 | DBMET00946 | |
| 0.012 | 0.366 | 0.051 | Protein kinase C eta inhibitor | 0.051 0.042 DBMET00946 | DBMET00946 | |
| 0.018 | 0.376 | 0.083 | 5 Hydroxytryptamine 3 agonist | 0.083 0.025 DBMET00617 | DBMET00617 | |
| 0.033 | 0.392 | 0.396 | Anesthetic general | 0.396 0.017 DBMET00617 0.162 0.101 DBMET00946 | DBMET00617 | |
| 0.029 | 0.39 | 0.196 | Cytidine deaminase inhibitor | 0.196 0.05 DBMET00617 | DBMET00617 | |
| 0.023 | 0.384 | 0.064 | Leukotriene C antagonist | 0.064 0.021 DBMET00617 0.058 0.033 DBMET00946 | DBMET00617 | |
| 0.004 | 0.366 | 0.043 | AMPA receptor antagonist | 0.043 0.04 DBMET00617 | DBMET00617 | |
| 0.016 | 0.38 | 0.057 | Glutamate (mGluR group III) antagonist | 0.049 0.022 DBMET00617 0.057 0.015 DBMET00946 | DBMET00946 | |
| 0.016 | 0.381 | 0.037 | Calcium-independent phospholipase A2 inhibitor | 0.037 0.015 DBMET00946 | DBMET00946 | |
| 0.011 | 0.378 | 0.076 | 5 Hydroxytryptamine 3A antagonist | 0.076 0.035 DBMET00617 | DBMET00617 | |
| 0.009 | 0.377 | 0.093 | Benzodiazepine agonist | 0.093 0.03 DBMET00617 | DBMET00617 | |
| 0.019 | 0.387 | 0.073 | Factor IXa inhibitor | 0.073 0.019 DBMET00946 | DBMET00946 | |
| 0.024 | 0.394 | 0.059 | Phosphodiesterase 1C inhibitor | 0.059 0.052 DBMET00617 | DBMET00617 | |
| 0.09 | 0.46 | 0.338 | Apoptosis antagonist | 0.338 0.062 DBMET00946 | DBMET00946 | |
| 0.015 | 0.386 | 0.037 | Leukotriene C4 antagonist | 0.037 0.034 DBMET00617 0.037 0.032 DBMET00946 | DBMET00946 | |
| 0.01 | 0.384 | 0.037 | MAP3K5 inhibitor | 0.037 0.031 DBMET00617 | DBMET00617 | |
| 0.009 | 0.383 | 0.059 | Leukotriene antagonist | 0.059 0.052 DBMET00946 | DBMET00946 | |
| 0.011 | 0.391 | 0.043 | GABA B receptor antagonist | 0.043 0.03 DBMET00617 | DBMET00617 | |
| 0.049 | 0.431 | 0.152 | Pregnane X receptor agonist | 0.152 0.049 DBMET00617 | DBMET00617 | |
| 0.056 | 0.442 | 0.243 | DNA directed DNA polymerase inhibitor | 0.243 0.196 DBMET00946 | DBMET00946 | |
| 0.004 | 0.389 | 0.016 | CC chemokine 9 receptor antagonist | 0.016 0.015 DBMET00617 | DBMET00617 | |
| 0.004 | 0.391 | 0.033 | Free fatty acid receptor 1 antagonist | 0.033 0.025 DBMET00617 | DBMET00617 | |
| 0.014 | 0.403 | 0.062 | Carnitine palmitoyltransferase 1B inhibitor | 0.062 0.015 DBMET00946 | DBMET00946 | |
| 0.004 | 0.394 | 0.066 | Guanylate cyclase inhibitor | 0.066 0.007 DBMET00617 | DBMET00617 | |
| 0.12 | 0.511 | 0.385 | Calcium channel L-type activator | 0.385 0.091 DBMET00946 | DBMET00946 | |
| 0.003 | 0.395 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.015 DBMET00617 | DBMET00617 | |
| 0.012 | 0.406 | 0.082 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.082 0.049 DBMET00617 | DBMET00617 | |
| 0.005 | 0.4 | 0.056 | Purinergic P2Y antagonist | 0.056 0.022 DBMET00946 | DBMET00946 | |
| 0.053 | 0.449 | 0.179 | Interferon gamma antagonist | 0.179 0.051 DBMET00617 0.164 0.062 DBMET00946 | DBMET00617 | |
| 0.029 | 0.43 | 0.185 | Amylase inhibitor | 0.185 0.05 DBMET00617 0.135 0.072 DBMET00946 | DBMET00617 | |
| 0.035 | 0.437 | 0.099 | Phosphodiesterase 6D inhibitor | 0.099 0.055 DBMET00617 | DBMET00617 | |
| 0.083 | 0.487 | 0.381 | Calcium channel activator | 0.381 0.032 DBMET00617 0.216 0.19 DBMET00946 | DBMET00617 | |
| 0.035 | 0.443 | 0.199 | Platelet antagonist | 0.199 0.102 DBMET00946 | DBMET00946 | |
| 0.01 | 0.42 | 0.619 | Cyclin-dependent kinase 5 inhibitor | 0.619 0.004 DBMET00617 | DBMET00617 | |
| 0.008 | 0.419 | 0.116 | Glutamate receptor agonist | 0.116 0.028 DBMET00946 | DBMET00946 | |
| 0.072 | 0.484 | 0.3 | RNA-directed DNA polymerase inhibitor | 0.3 0.032 DBMET00617 0.205 0.092 DBMET00946 | DBMET00617 | |
| 0.019 | 0.441 | 0.048 | Heme oxygenase inhibitor | 0.048 0.015 DBMET00617 | DBMET00617 | |
| 0.008 | 0.431 | 0.107 | Protein kinase (CK2) inhibitor | 0.088 0.074 DBMET00617 0.107 0.058 DBMET00946 | DBMET00946 | |
| 0.004 | 0.428 | 0.066 | Fructose-1,6-bisphosphatase inhibitor | 0.066 0.014 DBMET00617 | DBMET00617 | |
| 0.005 | 0.43 | 0.031 | ATP citrate lysase inhibitor | 0.031 0.023 DBMET00617 | DBMET00617 | |
| 0.012 | 0.438 | 0.074 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.074 0.019 DBMET00617 | DBMET00617 | |
| 0.022 | 0.449 | 0.12 | Neurotrophic factor | 0.12 0.095 DBMET00946 | DBMET00946 | |
| 0.03 | 0.46 | 0.083 | MDM2 inhibitor | 0.083 0.016 DBMET00617 0.067 0.048 DBMET00946 | DBMET00617 | |
| 0.021 | 0.452 | 0.311 | Aryl hydrocarbon receptor agonist | 0.311 0.058 DBMET00617 | DBMET00617 | |
| 0.007 | 0.439 | 0.076 | Xanthine dehydrogenase inhibitor | 0.076 0.027 DBMET00617 0.059 0.039 DBMET00946 | DBMET00617 | |
| 0.025 | 0.459 | 0.179 | I kappa B kinase epsilon inhibitor | 0.179 0.09 DBMET00617 0.14 0.131 DBMET00946 | DBMET00617 | |
| 0.007 | 0.442 | 0.113 | Protein kinase (CK2) alpha inhibitor | 0.107 0.071 DBMET00617 0.113 0.067 DBMET00946 | DBMET00946 | |
| 0.034 | 0.47 | 0.163 | Amyloid beta precursor protein antagonist | 0.163 0.088 DBMET00946 | DBMET00946 | |
| 0.008 | 0.449 | 0.088 | Retinoic acid alpha receptor agonist | 0.088 0.004 DBMET00946 | DBMET00946 | |
| 0.014 | 0.455 | 0.074 | Potassium channel intermediate-conductance Ca-activated blocker | 0.074 0.023 DBMET00617 | DBMET00617 | |
| 0.034 | 0.48 | 0.204 | Antiamyloidogenic | 0.204 0.097 DBMET00946 | DBMET00946 | |
| 0.013 | 0.462 | 0.044 | Vanilloid 3 antagonist | 0.044 0.015 DBMET00617 | DBMET00617 | |
| 0.021 | 0.47 | 0.138 | AMP-activated protein kinase stimulant | 0.138 0.036 DBMET00946 | DBMET00946 | |
| 0.036 | 0.488 | 0.18 | Streptokinase A inhibitor | 0.18 0.146 DBMET00617 | DBMET00617 | |
| 0.01 | 0.464 | 0.076 | Androgen antagonist | 0.076 0.071 DBMET00617 | DBMET00617 | |
| 0.061 | 0.516 | 0.211 | Toll-Like receptor 7 agonist | 0.211 0.188 DBMET00946 | DBMET00946 | |
| 0 | 0.466 | 0.009 | Mannitol 2-dehydrogenase inhibitor | 0.009 0.005 DBMET00946 | DBMET00946 | |
| 0.058 | 0.526 | 0.21 | Toll-Like receptor agonist | 0.21 0.19 DBMET00946 | DBMET00946 | |
| 0.014 | 0.49 | 0.059 | Autotaxin inhibitor | 0.059 0.03 DBMET00946 | DBMET00946 | |
| 0.027 | 0.511 | 0.115 | DNA polymerase I inhibitor | 0.115 0.072 DBMET00946 | DBMET00946 | |
| 0.006 | 0.496 | 0.066 | NMDA 2D receptor antagonist | 0.066 0.005 DBMET00946 | DBMET00946 | |
| 0.04 | 0.532 | 0.17 | Tumour necrosis factor antagonist | 0.17 0.077 DBMET00617 | DBMET00617 | |
| 0.082 | 0.578 | 0.26 | Interleukin 2 agonist | 0.26 0.108 DBMET00946 | DBMET00946 | |
| 0.015 | 0.536 | 0.157 | Toll-Like receptor 9 antagonist | 0.157 0.058 DBMET00617 | DBMET00617 | |
| 0.02 | 0.546 | 0.18 | Prostaglandin dehydrogenase inhibitor | 0.18 0.172 DBMET00617 | DBMET00617 | |
| 0.02 | 0.564 | 0.078 | Adenine nucleotide translocase inhibitor | 0.078 0.01 DBMET00946 | DBMET00946 | |
| 0.016 | 0.567 | 0.092 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.092 0.047 DBMET00946 | DBMET00946 | |
| 0.024 | 0.59 | 0.519 | Vasodilator | 0.519 0.01 DBMET00617 0.194 0.109 DBMET00946 | DBMET00617 | |
| 0.017 | 0.587 | 0.112 | Bone formation stimulant | 0.112 0.093 DBMET00946 | DBMET00946 | |
| 0.018 | 0.598 | 0.207 | Dual specificity phosphatase inhibitor | 0.207 0.051 DBMET00617 0.132 0.117 DBMET00946 | DBMET00617 | |
| 0.003 | 0.586 | 0.035 | Retinoid X beta receptor agonist | 0.035 0.007 DBMET00946 | DBMET00946 | |
| 0.013 | 0.598 | 0.099 | Beta amyloid protein antagonist | 0.099 0.091 DBMET00617 | DBMET00617 | |
| 0.029 | 0.618 | 0.253 | Hypoxia-inducible factor 1 alpha inhibitor | 0.253 0.098 DBMET00617 | DBMET00617 | |
| 0.048 | 0.648 | 0.188 | Lipocortins synthesis antagonist | 0.188 0.065 DBMET00946 | DBMET00946 | |
| 0.004 | 0.607 | 0.05 | Retinoic acid receptor agonist | 0.05 0.005 DBMET00946 | DBMET00946 | |
| 0.022 | 0.627 | 0.153 | Non-steroidal antiinflammatory agent | 0.153 0.112 DBMET00617 0.144 0.124 DBMET00946 | DBMET00617 | |
| 0.027 | 0.637 | 0.096 | ABCA1 expression enhancer | 0.096 0.055 DBMET00946 | DBMET00946 | |
| 0.028 | 0.64 | 0.121 | Interleukin 4 antagonist | 0.121 0.084 DBMET00946 | DBMET00946 | |
| 0.006 | 0.636 | 0.248 | Plasminogen activator inhibitor antagonist | 0.248 0.004 DBMET00617 | DBMET00617 | |
| 0.004 | 0.635 | 0.066 | Nicotinic acid receptor 2 agonist | 0.066 0.01 DBMET00946 | DBMET00946 | |
| 0.01 | 0.643 | 0.045 | DNA gyrase subunit A inhibitor | 0.045 0.024 DBMET00617 0.039 0.038 DBMET00946 | DBMET00617 | |
| 0.009 | 0.656 | 0.166 | Mcl-1 antagonist | 0.166 0.076 DBMET00946 | DBMET00946 | |
| 0.012 | 0.669 | 0.322 | Dual specificity phosphatase 3 inhibitor | 0.322 0.025 DBMET00617 | DBMET00617 | |
| 0.03 | 0.691 | 0.134 | Hepatoprotectant | 0.134 0.129 DBMET00946 | DBMET00946 | |
| 0.003 | 0.669 | 0.038 | Retinoid X gamma receptor agonist | 0.038 0.008 DBMET00946 | DBMET00946 | |
| 0.011 | 0.693 | 0.04 | Glutamate (mGluR8) antagonist | 0.04 0.017 DBMET00946 | DBMET00946 | |
| 0.005 | 0.719 | 0.072 | DNA gyrase inhibitor | 0.072 0.034 DBMET00617 | DBMET00617 | |
| 0.009 | 0.73 | 0.068 | Prostaglandin F2 alpha antagonist | 0.068 0.034 DBMET00946 | DBMET00946 | |
| 0.002 | 0.726 | 0.03 | Retinoic acid alpha receptor antagonist | 0.03 0.006 DBMET00946 | DBMET00946 | |
| 0.004 | 0.734 | 0.129 | Protein-tyrosine phosphatase 1B inhibitor | 0.129 0.056 DBMET00946 | DBMET00946 | |
| 0.004 | 0.749 | 0.094 | Prostaglandin E2 antagonist | 0.094 0.016 DBMET00946 | DBMET00946 | |
| 0.004 | 0.752 | 0.048 | Purinergic P2Y14 antagonist | 0.048 0.008 DBMET00946 | DBMET00946 | |
| 0.003 | 0.769 | 0.032 | Retinoic acid beta receptor agonist | 0.032 0.005 DBMET00946 | DBMET00946 | |
| 0.004 | 0.772 | 0.03 | Retinoic acid gamma receptor agonist | 0.03 0.006 DBMET00946 | DBMET00946 | |
| 0.001 | 0.77 | 0.015 | Retinoic acid beta receptor antagonist | 0.015 0.005 DBMET00946 | DBMET00946 | |
| 0.003 | 0.784 | 0.03 | Retinoid X gamma receptor antagonist | 0.03 0.012 DBMET00946 | DBMET00946 | |
| 0.012 | 0.797 | 0.127 | Farnesoid X receptor antagonist | 0.127 0.088 DBMET00946 | DBMET00946 | |
| 0.002 | 0.787 | 0.014 | Retinoic acid receptor gamma antagonist | 0.014 0.006 DBMET00946 | DBMET00946 | |
| 0.005 | 0.794 | 0.191 | Protein-tyrosine phosphatase inhibitor | 0.191 0.05 DBMET00946 | DBMET00946 | |
| 0.017 | 0.821 | 0.238 | Hypoglycemic | 0.238 0.084 DBMET00946 | DBMET00946 | |
| 0.004 | 0.815 | 0.055 | Prostaglandin EP2 antagonist | 0.055 0.046 DBMET00946 | DBMET00946 | |
| 0.002 | 0.823 | 0.026 | Retinoic acid receptor antagonist | 0.026 0.007 DBMET00946 | DBMET00946 | |
| 0.005 | 0.915 | 0.108 | Uric acid excretion stimulant | 0.108 0.045 DBMET00946 | DBMET00946 | |
| 0.006 | 0.917 | 0.283 | Cyclophilin D inhibitor | 0.283 0.178 DBMET00946 | DBMET00946 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |